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Abstract 
My PhD research focus has been the study of lipoic acid and biotin metabolism in 
several bacteria. Lipoic acid and biotin are essential enzyme cofactors found in all three 
domains of life. Both molecules function only when covalently attached to key metabolic 
enzymes, 2-oxoacid dehygrogenase (OADH) and glycine cleavage H protein (GcvH). 
There they act as “swinging arms” that transfer intermediates between two active sites 
of key metabolic enzymes by covalent substrate channeling. Escherichia coli and 
Bacillus subtilis are the two organisms with well characterized but quite distinct models 
for lipoic acid and biotin metabolism. In this thesis I made further studies about lipoic 
acid synthesis genes in other organisms and resolved remaining questions in biotin 
synthesis. I also discovered novel functions and mechanisms of proteins involved in 
lipoic acid metabolic pathway by bacteria genetics and biochemical assays.  
 
In the second chapter I investigated the lipoate-protein liagase (LplA) from 
Streptomyces coelicolor. LplA enzymes function to scavenge lipoic acid from the 
environment and attach the coenzyme to its cognate proteins, which are generally the 
E2 components of the 2-oxoacid dehydrogenases. The LplA reaction is catalyzed in two 
steps: (1) LplA activates lipoate to lipoyl-AMP, (2) LplA transfers the lipoyl-moiety from 
lipoyl-AMP to the cognate protein. The S. coelicolor genome encodes only a single 
putative lipoate ligase and this protein had very low sequence identity to the well 
characterized E. coli LplA (<25%) and has the domain order reversed relative to the E. 
coli protein. I tested the activity of S. coelicolor LplA both by in vivo complementation of 
an E. coli ligase-deficient strain and by in vitro assays. Moreover, when I rearranged S. 
coelicolor LplA into one that mimicked the arrangement found in the canonical lipoate 
ligases, the enzyme retained complementation activity. Finally, when the two domains 
were separated into two proteins, both domain-containing proteins were required for 
complementation and catalysis of the overall ligase reaction in vitro. However, only the 
large domain-containing protein was required for transfer of lipoate from the lipoyl-AMP 
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intermediate to the acceptor proteins, whereas both domain-containing proteins were 
required to form lipoyl-AMP. 
 
In the third chapter, I unraveled the puzzle of different BioH proteins-one of the 
enzymes involved in biotin biosynthesis. The late steps of biotin synthesis, which are 
responsible for assembly of the rings, are conserved among different organisms and 
were well described biochemically years ago. These steps comprise a cluster of four 
genes, bioABFD. In contrast, the early steps of biotin synthesis, assembly of the valeric 
acid side-chain of biotin were determineded recently in E. coli and only two genes, bioC 
and bioH are required for this. The BioC methyltransferase disguises the substrate to 
allow entry into the fatty acid synthesis pathway by methylating the free carboxyl of 
malonyl-acyl carrier protein (ACP). When chain has been elongated to seven carbons, 
the disguise is removed the BioH esterase. Although the biotin synthesis pathway has 
been well demonstrated, there remained a puzzle. In E. coli, the bioH (“freestanding” 
bioH) gene is located at a site well removed from the biotin synthetic operon and is not 
regulated by the BirA repressor whereas in other proteobacteria (e.g., the 
pseudomonads) the bioH gene (“operon-encoded” bioH) is found in an apparent biotin 
operon and in general is located immediately upstream of bioC. Moreover, E. coli BioH 
is a rather promiscuous hydrolase and has much higher enzymatic activity compared to 
the other biotin synthetic enzymes. In this chapter, I compared and contrasted the two 
different kinds of bioH: “freestanding” bioH from E. coli and “operon-encoded” bioH from 
P. aeruginosa in terms of their enzymatic activity, substrate specificity, transcription and 
translation levels. I found both BioHs have similar high enzymatic activity and broad 
range of substrate specificity. However, the “freestanding” bioH is transcribed and 
translated at lower levels than the “operon-encoded” bioH. 
In the fourth chapter we investigated a remarkable case in which the GcvH protein’s 
“moonlighting” function (i.e., development of a new function while retaining the original 
function) is found throughout evolution in the absence of selection. The B. subtilis lipoic 
acid synthesis pathway is primordial due to the fact that GcvH is the only substrate for 
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lipoate assembly. Hence in B. subtilis, lipoic acid-requiring 2-oxoacid dehydrogenase 
(OADH) proteins acquire the cofactor only by transfer from lipoylated GcvH. The E. coli 
pathway where lipoate is directly assembled on both its GcvH and OADH proteins, is 
proposed to arise later. Since roughly two billion years separate the divergence of these 
two bacteria (E. coli and B. subtilis), it is surprising that E. coli GcvH functionally 
substitutes for the B. subtilis protein in lipoyl transfer. I tested several known and 
putative GcvHs from other bacteria and eukaryotes by in vivo complementation and in 
vitro enzymatic assays and found they could also substitute for B. subtilis GcvH in 
OADH modification.  
 
In the fifth chapter, I summarize my findings and give my outlooks especially for 
avenues of lipoic acid metabolism studies. Science is so beautiful and there are 
numerous interesting questions that haven’t been fully studied yet. I hope my thesis will 
provide insight and thoughts for people in the future study of lipoic acid and biotin 
related problems.  
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CHAPTER 1 
 INTRODUCTION 
Metabolic Roles and Structure of Lipoic Acid 
Lipoic acid is an essential sulfur-containing cofactor found in eukaryotes, in most 
bacteria and some archaea. It serves as a “universal” antioxidant and helps prevent 
diabetes, cardiovascular diseases and cancer. Unlike most cofactors, lipoic acid is 
required for the function of several key enzymes involved in central carbon 
metabolism (Perham 2000). The 2-oxoacid dehydrogenases and the glycine 
cleavage system (GCV) contain lipoyl domains (LD): highly conserved domains 
containing a specific lysine residue to which lipoic acid is attached (Cronan, Zhao et 
al. 2005, Cronan 2014) by an amide linkage between the lipoic acid carboxyl group 
and the ɛ-amino group of the lysine residue. The lipoyl moiety plays a unique role in 
catalysis. The terminal dithiolane ring becomes reduced and acylated with a reaction 
intermediate whereas the lipoyl-lysine arm serves as a tether and a highly mobile 
carrier of reaction intermediates between the active sites of these multienzyme 
complexes (Perham 2000). 
 
Lipoic acid is also called thioctic acid, 6,8-dithiooctanoic acid, and α-lipoic acid. Like 
a lipid, lipoic acid is poorly soluble in water but is highly soluble in organic solvents 
(Reed 1998, Reed 2001). The backbone of lipoic acid is the short-chain fatty acid 
octanoic acid (Figure 1-1). Lipoic acid was first isolated from liver extracts by jointed 
forces from Gunsalus, Reed and coworkers which were greatly aided by large scale 
processing from Eli Lilly. Only 30 mg of lipoic acid was isolated from about 10 tons of 
liver (Reed, De et al. 1951). Lipoic acid was thought to contain a dithiol because 
lipoic acid catalyzed-pyruvate oxidation in pigeon brain tissue was inhibited by 
trivalent organoarsenic compounds (such as Lewisite). These compounds were 
known to tightly bind 1,2- and 1,3-dithiols, and inhibition was reversible by the 
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addition of a 1,2-dithiol (Peters 1952). This was confirmed later when the correct 
structure of lipoic acid was established by chemical synthesis (Stokstad 1954). 
Lipoic Acid Dependent Enzyme Complexes 
There are five lipoate-dependent multienzyme complexes have been characterized 
and published. Four are 2-oxoacid dehydrogenases: pyruvate dehydrogenase (PDH), 
α-ketoglutarate dehydrogenase (KGDH), branched-chain 2-oxoacid dehydrogenase 
(BCDH), and acetoin dehydrogenase (AoDH) (Perham 1991, Perham 1995, Perham 
2000). These complexes are composed of multiple enzymatic subunits referred to as 
E1, E2 and E3. The core of the enzyme complexes is provided by the E2 subunit, to 
which the E1 and E3 components are tightly bound. The fifth complex, the glycine 
cleavage complex (GCV), has a quite different architecture compared to the 2-
oxoacid dehydrogenases. It is composed of four loosely associated proteins called 
the P, H, T, and L protein (Douce, Bourguignon et al. 2001). The lipoate cofactor is 
attached trough an amide bond to a highly conserved lysine residue on the H protein 
of GCV (GcvH) or lipoyl domains (LDs)2 located at the E2 subunit of 2-oxoacid 
dehydrogenase. During catalysis, the intramolecular disulfide bond of lipoate cycles 
between oxidized and reduced form (Figure 1-2). 
 
Just until recently, by collaborating with Dr. Dahl’s group from University of Bonn in 
Germany, we characterized another group of protein that requires the binding of 
lipoic acid, called lipoate binding protein (Lbp) (data unpublished). Comparative 
genome analysis (Quatrini, Appia-Ayme et al. 2009, Venceslau, Stockdreher et al. 
2014, Dahl 2015), and proteomic studies (Quatrini, Appia-Ayme et al. 2009, Mangold, 
Valdes et al. 2011, Osorio, Mangold et al. 2013, Latorre, Ehrenfeld et al. 2016) 
indicate that Lbp appear to be associated with a heterodisulfide reductase (Hdr)-like 
enzyme complex, which is encoded by hdrBC1B1A-hyp-hdrC2B2 gene cluster 
among a large group of archaeal and bacterial sulfur oxidizers. Phylogenetic 
analysis separates Lbp proteins into two clearly distinct groups, LbpA1 and LbpA2. 
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Both LbpA1 and LbpA2 could be lipoylated by a lipoate protein ligase encoded in the 
same hdr gene cluster (data unpublished).  
Pyruvate dehydrogenase (PDH), α-ketoglutarate dehydrogenase (KGDH) and 
branched-chain 2-oxoacid dehygrogenase (BCDH) are also called 2-oxoacid 
dehydrogenase complexes due to the fact that all three complexes catalyze the 
decarboxylation of 2-oxoacids to produce acyl coenzyme A (acyl-CoA), NADH, and 
CO2 by similar reaction mechanisms (Figure 1-3A). In the first reaction step, the E1 
subunit decarboxylates the 2-oxoacid substrate, and the acyl group is then 
transferred to lipoyl moiety located on the E2 subunit. The E2 subunit has catalytic 
activity that consecutively transfers the acyl group to coenzyme A (CoA). The lipoyl 
moiety is regenerated through reduction of NAD+ by the E3 subunit. The end product 
acyl-CoA of PDH and OGDH are required for carbon entry into the tricarboxylic acid 
(TCA) cycle and carbon progression through the cycle, respectively, whereas the 
BCDH is required for synthesis of branched-chain fatty acids in bacteria and 
degradation of branched-chain amino acids in mammals (Cronan 2016). The acetoin 
dehydrogenase (AoDH) is closely related to pyruvate dehydrogenase and is thought 
to have evolved from a common PDH ancestor (Kruger, Oppermann et al. 1994), but 
does not have a 2-oxoacid substrate. Other than the generation of acetaldehyde 
(rather than CO2), the reactions catalyzed by AoDH are identical to those catalyzed 
by PDH and result in the formation of acetyl-CoA. 
 
In all 2-oxoacid dehydrogenase complexes, lipoic acid is bound to a highly 
conserved to lysine residue at the tip of the protruding β-turn of lipoyl domain (LD) 
that is located on E2 subunit. The E2 subunit has a multi-domain structure and is 
composed of (from the N terminus): lipoyl domain (or domains ≈ 9 kDa), a small 
peripheral subunit-binding domain (≈ 4 kDa) and much larger catalytic domain (≈ 28 
kDa) that houses the acyltransferase activity and aggregates to form the inner core 
of the complexes. (Perham 1991)The conserved structure of lipoyl domain(s) (Figure 
1-3C) play a direct role for catalytic functions in substrate channeling and active-site 
4 
 
coupling within the whole 2-oxoacid dehydrogenase complexes. The biochemical 
properties of lipoyl domains are very similar to acyl-carrier protein (ACP) that is 
involved in fatty acid synthesis pathways. Both lipoyl domain and ACP are very small, 
acidic proteins. The number of lipoyl domains per E2 subunit varies from one to 
three. The PDH complexes of Gram-negative bacteria usually contain two or three 
lipoyl domains, whereas the E2o chain of OGDH complexes only contain a single 
lipoyl domain, as is also true for the E2b chain of all BCDH complexes (Reed and 
Hackert 1990, Perham 1991, Berg and de Kok 1997, Perham 2000).  
 
Lipoic acid attachment is also required for glycine cleavage complex (GCV), the 
reaction of which is very different from those of 2-oxoacid dehydrogenase. GCV 
catalyze the cleavage of glycine to N5, N10-methylene-tetrahydrofolate, CO2, and 
NH3 (Figure 1-3B) and provide nitrogen source for cells. GCV is composed of four 
proteins: GcvH, GcvT, GcvP and GcvL. GcvH is the lipoate attachment protein that 
consists of a single lipoyl domain (LD) (Kikuchi 1973, Kikuchi, Motokawa et al. 2008). 
During catalysis, the lipoyl moiety of GcvH successively undergoes methylamination 
(catalyzed by GcvP), methylamine transfer (catalyzed by GcvT) and oxidation 
(catalyzed by GcvL, also used by 2-oxoacid dehydrogenase). The B. subtilis GcvH is 
atypical from those of gram-negative bacteria such as E. coli in that it is an obligate 
intermediate for lipoylation of the 2-oxoacid dehydrogenase proteins. That is the 
reason why B. subtilis ∆gcvH strain is not able to make lipoate and it is auxotrophic 
for lipoate (Christensen and Cronan 2010). Moreover, the lipoate-relay ability of B. 
subtilis GcvH has been retained in the GcvH proteins of bacteria (E. coli, S. 
coelicolor, etc) that have no use for this proficiency because they utilize a different 
and more efficient lipoylation pathway, the LipB-LipA pathway (see chapter 4).   
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Biosynthesis and Scavenge of Lipoic Acid 
The function and structure of proteins involved in lipoic acid metabolism were best 
established in E. coli. In E. coli, lipoic acid may be directly scavenged from the 
environment or synthesized de novo (Morris, Reed et al. 1995, Zhao, Miller et al. 
2003, Cronan, Zhao et al. 2005, Hermes and Cronan 2009, Cronan 2014). 
Depending on the source of lipoic acid, studies in our laboratory and others have 
elucidated two independent pathways in E. coli (Figure 1-4). If lipoic acid is available 
in the environment, LplA catalyzes both the ATP-dependent activation of lipoate to 
lipoyl-adenylate (lipoyl-AMP) as well as the subsequent transfer of this activated 
lipoyl species to an apo LD (e.g., the E2 subunit of a 2-oxoacid dehydrogenase) with 
concomitant release of AMP (Figure 1-4) (Morris, Reed et al. 1994, Morris, Reed et 
al. 1995). When exogenous lipoic acid is absent, LipB, an octanoyl-ACP (acyl carrier 
protein) transferase, transfers the octanoyl moiety from the fatty acid biosynthetic 
intermediate, octanoyl-ACP, to the LD of a lipoate-accepting protein. The 
octanoylated domains then become substrates for sulfur insertion by LipA, radical 
SAM (S-adenosylmethionine) enzyme that replaces single hydrogen atoms on 
carbons 6 and 8 of octanoate with sulfur atoms (Cicchillo and Booker 2005) to yield 
dihydrolipoyl-LD which becomes oxidized to lipoyl-LD (Figure 1-4). The mechanism 
of LipA was long to be a conundrum in the field. The second or auxiliary [4Fe-4S] 
cluster of LipA was believed to provide the two sulfur atoms and to fall apart during 
the reaction (Cicchillo and Booker 2005, Lanz, Pandelia et al. 2014). However, it 
was not clear how LipA can still be an enzyme if it is destroyed during a single 
reaction until the recent experimental evidence provide by McCarthy and Booker. 
They show that another protein, NfuA, delivers a new [4Fe-4S] cluster to LipA and 
does so rapidly enough so as to not impede catalysis (McCarthy and Booker 2017).  
 
The detailed mechanisms of lipoic acid synthesis and attachment to target proteins 
are less well understood and more complicated in other organisms including 
eukaryotes. It appeared that Bacillus subtilis adopts a rather different de novo lipoate 
synthetic strategy compared to E. coli (Figure 1-5) (Christensen, Martin et al. 2011, 
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Martin, Christensen et al. 2011). In B. subtilis, two additional proteins are required 
for lipoate synthesis. The octanoyltransferase, LipM, equivalent to LipB in E. coli (but 
virtually LipM having no sequence resemblance to E. coli LipB), transfers the 
octanoyl moiety from the ACP of fatty acid biosynthesis specifically to GcvH 
(Christensen and Cronan 2010, Martin, Christensen et al. 2011). Then the octanoyl 
moiety is transferred by LipL, a novel GcvH:E2 amidotransferase, from GcvH to apo-
LD of E2 subunits (Christensen, Martin et al. 2011). In B. subtilis, GcvH is required 
as octanoyl moiety carrier, without which the apo-LDs of 2-oxoacid dehydrogenase 
E2 subunits would not be lipoylated. This was baffling, as it is difficult to speculate 
how a protein that is the target of lipoylation itself becomes required for lipoylation of 
other proteins. The true lipoate-protein ligase of B. subtilis is LplJ, which is an 
isozyme of E. coli LplA. The same case was also found with Saccharomyces 
cerevisiae.  In S. cerevisiae, Lip3, a lipoate-protein ligase homolog was shown to be 
required with Lip2 and Lip5 (the respective yeast homologs of E. coli LipB and LipA) 
for the lipoylation of the target proteins. Other than that, Gcv3, the GcvH protein of S. 
cerevisiae is also needed for lipoic acid synthesis (Schonauer, Kastaniotis et al. 
2009).  
                            
Lipoate-protein Ligase (LplA)  
The E. coli lplA gene was the first lipoate-protein ligase gene to be isolated and LplA 
protein was the first ligase purified to homogeneity (Green, Morris et al. 1995) (Morris, 
Reed et al. 1994). The lplA gene was identified by two different approaches. In the first 
approach, a lipA mutant strain was mutagenized by transposon insertion. Then the 
mutagenized cells were screened for the availability to grow on succinate-acetate (to 
bypass lipoate requirement) supplemented medium, but not able to grow on lipoate 
supplemented medium. The screening result showed all the isolated mutants were lplA 
mutants. The lack of lipoate transport mutant suggests that there may be no specific 
transporter for lipoate in E. coli and lipoate can go into the cell by simple diffusion as the 
case for short chain fatty acid (lipoic acid is a derivative of octanoic acid). The second 
approach was selection for strains resistance to selenolipoic acid, a growth-inhibitory 
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lipoate analogue in which the sulfur atoms are replaced by selenium (Reed, Morris et al. 
1994). 
 
The size of purified monomeric E. coli LplA is 38 kDa (Green, Morris et al. 1995). The 
crystal structure of E. coli LplA plus an LplA-lipoic acid complex has been reported 
(Fujiwara, Toma et al. 2005, Kim, Kim et al. 2005). E. coli LplA contains a large N-
terminal catalytic domain and a small auxiliary C-terminal domain which are connected 
by a glycine rich polypeptide linker (Figure 1-6). In the lipoate activation partial reaction, 
the small domain of E. coli LplA moves toward the large domain to form the U-shaped 
lipoyl-AMP binding pocket, so that the substrate is well shielded from solvent. In the 
second partial reaction, the small domain rotates away from the large domain by 
~180°.The rotation step is essential to give apoprotein enough space to approach the 
LplA for the lipoate transfer reaction (Fujiwara, Maita et al. 2010). The conserved 
Lys133 catalytic residue plays essential roles in both the lipoyl-AMP formation and 
lipoate transfer steps. 
 
Lipoate-protein Ligase belongs to the Pfam PF03099-A biotin/lipoate A/B protein ligase 
family that is constructed on the same scaffold and includes both classical ligases and 
other enzymes catalyzing acyl transfer, such as amidotransferases and 
octanoyltransferases (Cronan 2016). The classical lipoate ligases seem to have a 
consistent overall architecture: a large catalytic domain and a small auxiliary domain at 
either the C-terminus of the protein such as E. coli LplA, or at the N-terminus such as 
Streptomyces coelicolor LplA (Cao and Cronan 2015), or the small accessory domain 
be encoded by a completely separate gene, such as the Thermoplasma acidophilum 
LplB (McManus, Luisi et al. 2006, Christensen and Cronan 2009, Posner, Upadhyay et 
al. 2009). As mentioned above, LipB (an octanoyltransferase) and LipM (an 
amidotransferase) also belongs to the same Pfam family and both of them have only a 
single-domain structure. However, LipB and LipM share almost no sequence 
conservation and moreover the enzymes diverge in that their active site cysteine 
residues are on different loops of the common scaffold (Christensen and Cronan 2010). 
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Very interestingly, by collaborating with Dr. Christiane Dahl (Bonn,Germany) we just set 
out to verify a novel group of bifunctional proteins in sulfur-oxidizing bacteria 
(Hyphomicrobium denetrificans, Thioalkalivibrio sp. K90mix, etc) that is poised to have 
both lipoate ligase activity and octanoyl transferase activity (data not published yet). To 
our surprise, this group of proteins only possesses a single domain (Figure 1-7) which 
breaks the canonical rule that a conventional lipoate-protein ligase should have two 
domains in order to catalyze the two partial reactions (activation of lipoic acid to lipoyl-
AMP and transferring lipoate moiety from lipoyl-AMP to apoproteins). In addition, the 
dual catalytic activity of this group of proteins is restricted in kind to apoproteins that are 
readily divided into two distinct groups and both are involved in sulfur oxidation 
pathways. A crystal structure of that bifunctional LplA and LplA-acceptor protein 
complex is highly valuable in this regard.  
 
The most curious of lipoate ligase family proteins are the human and bovine lipoyl 
transferase LipT1, which is orthologous to bacterial lipoate protein ligase LplA. Human 
patients with LipT1 mutation die early in life or suffer from lactic acidosis. 
Previous studies showed that bovine LipT1 was unable to catalyze the first partial 
reaction: synthesis of the adenylate, but was able to transfer the lipoate moiety from 
lipoyl-adenylate to both LDs and GcsH in vitro (Fujiwara, Okamura-Ikeda et al. 1994). 
This gives rise to the proposal that mammalian lipoate synthesis requires an additional 
“lipoate-activating enzyme”. Later, the same group demonstrated that the “lipoate-
activating enzyme” turned out to be acyl-CoA synthetase (ACSM1) (Fujiwara, Takeuchi 
et al. 2001), which is an extremely promiscuous enzyme (Vessey, Lau et al. 2000, 
Kasuya, Tatsuki et al. 2006). Additionally the physiological relevance of ACSM in vitro 
lipoyl-GMP instead of lipoyl-AMP forming activity is still unclear. More importantly in  
2013, Soreze et al and Tort et al respectively found that patients with lipT1 gene 
mutations have a fatal disease (Soreze, Boutron et al. 2013, Tort, Ferrer-Cortes et al. 
2014) associated with specific lipoylation defects of the LD from PDH (pyruvate 
dehydrogenaswe) and KGDH (2-ketoglutarate dehydrogenase). However, the 
lipoylation of GcsH, levels of glycine cleavage activity and body fluids glycine were 
surprisingly normal (Soreze, Boutron et al. 2013, Tort, Ferrer-Cortes et al. 2014).  
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Meanwhile, addition of lipoic acid to the growth medium of fibroblasts derived from 
patients failed to restore lipoylation (Soreze, Boutron et al. 2013, Tort, Ferrer-Cortes et 
al. 2014) whereas introduction of a wild type lipT1 gene restored fibroblast 2-oxoacid 
dehydrogenase activities (Soreze, Boutron et al. 2013).  
 
The above studies clearly demonstrate that mammalian LipT1 lack the ability to attach 
exogenous lipoic acid to the essential enzymes that require the lipoyl cofactor for 
activity. Our hypothesis is that the true physiological activity of LipT1 is amidotransfer, 
the same activity as of LipM protein in B. subtilis and the half ligase activity of LipT1 is 
just a remnant of enzyme evolution that has long misled the field. I purified bovine LipT1 
and confirmed its amidotransferase activity in vitro: transfer of lipoyl moiety from lipoyl-
GcsH to apo-LD of 2-oxoacid dehydrogenase (data not published yet). Interestingly, my 
preliminary data showed that LipT1 has very low activity upon octanoyl-GcsH 
(experiments need to be further confimed). Through in vitro biochemical assays, we 
also showed that the endogenous synthesis of lipoyl-GcsH was catalyzed by LipT2, 
which is an ortholouge of LipB protein and could complement an E. coli lipB mutant 
strain and allow lipoate-independent growth (data not published yet).  
Bacterial Biotin Metabolism 
Biotin, also known as vitamin H or B7 is an essential enzyme cofactor found in all three 
domains of life. The cofactor is necessary for critical steps of central metabolism 
including fatty acid synthesis and amino acid degradation (Agarwal, Lin et al. 2012). De 
novo synthesis of biotin is restricted to archea, bacteria, plants and a few fungi (Alban 
2011). Animals, including humans, cannot synthesize biotin and must rely on 
exogenous sources for biotin and thus the enzymes of biotin biosynthesis are attractive 
drug targets for development of novel antibacterial agents (Zlitni, Ferruccio et al. 2013, 
Park, Casalena et al. 2015). Biotin shares many similarities to lipoic acid and it has 
been the subject of an excellent review written by Dr. John Cronan (Cronan 2014). Thus, 
only an overview of bacterial biotin metabolism will be given here.  
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Similar to lipoic acid, biotin also functions only when covalently attached to its cognate 
proteins which are involved in key metabolic carboxylation and decarboxylation 
reactions. There biotin acts as part of a long “swinging arm” that transfers intermediates 
between active sites of key metabolic enzymes by covalent substrate channeling 
(Figure 1-8B) (Waldrop, Holden et al. 2012, Tong 2013, Cronan 2014).Biotin consists of 
two fused heterocyclic rings plus a valeric acid chain (Figure 1-8A) (DeTitta, Edmonds 
et al. 1976). The biotin synthesis pathway can be readily divided into early and late 
stages. The enzymes of the late stage, those required for the assembly of the two 
heterocyclic rings, are strongly conserved across the archea, bacteria, plants and fungi 
and their biochemistry and structures are well understood. In E. coli and many other 
bacteria these steps are encoded in a gene cluster (bioABFCD) which often is regulated 
by BirA, a bifunctional protein that acts both as a biotin-protein ligase and a 
transcriptional repressor (Barker and Campbell 1981, Barker and Campbell 1981). In 
contrast the early stage, that responsible for synthesis of the pimelate thioester that 
contributes to the valeric side chain and the first ring carbons, is quite diverse. The 
pathway for synthesis of this moiety was demonstrated only recently in E. coli and 
consists of enzymes encoded by the bioH and bioC genes that allow the fatty acid 
synthesis pathway to make pimelate, a seven carbon dicarboxylic acid (Lin, Hanson et 
al. 2010, Lin and Cronan 2011). BioC, a carboxyl methyltransferase, initiates biotin 
synthesis by methylation of the free carboxyl group of a fraction of the key fatty acid 
synthetic intermediate, malonyl-ACP and thereby appropriates a small portion of 
malonyl-acyl carrier protein (ACP) from the type II fatty acid synthesis pathway. 
Methylation of the free carboxyl of malonyl-ACP disguises the substrate and allows its 
entry into the fatty acid synthesis pathway (Christensen and Cronan 2010, Waldrop, 
Holden et al. 2012). When the acyl chain has been elongated to seven carbons, the 
disguise is (and must be) removed by the BioH pimeloyl-ACP methyl ester esterase (Lin, 
Hanson et al. 2010).  
 
The synthesis of pimelate moiety in B. subtilis is quite different from that in E. coli. Two 
redundant genes bioW and bioI are involved (Bower, Perkins et al. 1996). BioW is a 
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pimeloyl-CoA synthetase that converts pimelic acid to pimeloyl-CoA . Deletion of bioW 
in B. subtilis results in biotin auxotrophy suggesting bioW is essential for biotin synthesis 
(Manandhar and Cronan 2017 b). However it was elusive for the resource of free 
pimelic acid was elusive because this molecule is neither found in central metabolism 
nor is abundant in known environments. Just until recently, this conundrom was 
resolved by Manandhar and Cronan that the free pimelic acid originates from fatty acid 
sythesis pathway (Manandhar and Cronan 2017 b). They showed that Inhibition of FabF, 
which is the key fatty acid elongation enzyme, markedly reduced biotin production 
wherase an inhibitor-resistant strain produce more biotin.  BioI is an enzyme of the 
cytochrome P450 family and is believed to provide the de novo synthesis of pimeloyl-
ACP by catalyzing the C-C bond cleavage of long-chain acyl-ACPs (Stok and De Voss 
2000). B. subtilis ∆bioI mutant strain is not biotin auxotrophic indicating that bioI is 
dispensable in biotin synthesis. Later Manandhar and Cronan beautifully explained why 
bioW is essential for biotin styntheis whereas bioI is not. They showed by both in vivo 
and in vitro studies that B. subtilis BioF, which is responsible for catalyzing the first step 
in assembly of the fused hetercyclic rings of biotin, specificly accepts pimeloyl-CoA but 
not pimeloyl-ACP as the pimeloyl-moiety donor (Manandhar and Cronan 2017 a). 
 
 Aim and Scope of This Thesis 
Although the metabolic role of lipoic acid dependent enzyme complexes has been well 
esblished and the two classical lipoic acid synthesis pathway models have been clearly 
characterized in E. coli and B. sutbilis respectively, the details of lipoic acid metabolism 
in other organisms are still less clear. There are also questions remaining in biotin 
synthesis. The primary aim of this thesisis to obtain a further study of the mechanisms 
of major proteins involved in lipoic acid and biotin synthesis pathways from different 
organisms.  
 
In Chapter 2, I characterized the enzymatic funtion of lipoate-protein ligase (LplA) from 
Streptomyces coelicolor. The interest to study this protein is because it seemed to have 
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circularly permutated architecture relative to the well characterized E. coli LplA protein. 
E. coli LplA has a large N-terminal domain that contains the lipoic acid-binding site plus 
a small C-terminal domain (Figure 1-6). In the S. coelicolor protein, the small domain 
appears to have been transposed to the N-terminus. Additionaly, S. coelicolor LplA has 
very low sequence identity (<25%) to E. coli LplA even after the small domain is 
transposed back to that of the E. coli LplA location. In this project, I rearranged the 
domain architecure of S. coelicolor LplA into that of the conanical lipoate ligases, and 
found the new protein still retained its activity in vivo but had remarkably reduced 
catalytic activity in vitro. The most challenging part of this project was to find a proper 
cleavage site between the two domains without  disturbing of the original domain 
structure. Five candidate cleavage sites were tried and only one worked, although much 
of the protein ended up in inclusion bodies during purification. Finally, when the two 
domains were separated into two distinct proteins, both domain-containing proteins 
were required to form lipoyl-AMP, whereas the large domain is sufficient for transfer of 
lipoate from the lipoyl-AMP intermediate to the acceptor proteins. 
 
In Chapter 3, I unraveled the puzzle of BioH proteins-one of biotin synthesis enzymes. 
In E. coli, the bioH (referred to as “freestanding bioH”) gene is located at a site well 
removed from the biotin synthetic operon and is not regulated by the BirA repressor 
whereas in other proteobacteria (e.g., the pseudomonads) the bioH gene (referred to as 
“operon-encoded bioH”) is found in an apparent biotin operon and in general is located 
immediately upstream of bioC. Moreover, E. coli BioH is a rather promiscuous 
hydrolase and has much higher catalytic activity compared to the other biotin synthetic 
enzymes (BioA, BioB and BioD, etc). In this chapter, I compared and contrasted the two 
different kinds of bioH: freestanding bioH from E. coli and operon-encoded bioH from 
Pseudomonas aeruginosa in terms of their enzymatic activity, substrate specificity, 
transcription and translation levels. I found both BioH proteins have similar high 
enzymatic activity and broad range of substrate specificity. However, the freestanding 
bioH is transcribed and translated at lower levels than the operon-encoded bioH.  
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In Chapter 4, I found most GcvH proteins from eukaryotes and bacteria including E. coli 
and the deep-branching chemoautotrophic bacterium, Aquifex aeolicus, also having 
lipoyl relay activity in B. subtilis in addition to their original glycine clevage activity. This 
is unexpected and puzzling given the roughly two billion years of divergence between 
gram-negative and gram-positive bacteria. In B. subtilis GcvH is the only substrate for 
lipoate assembly. Hence lipoic acid-requiring 2-oxoacid dehydrogenase (OADH) 
proteins acquire the cofactor only by transfer from lipoylated GcvH. The Escherichia coli 
pathway where lipoate is directly assembled on both its GcvH and OADH proteins, have 
been proposed to arise later. The chemically challenging nature of lipoyl transfer 
strengthens this argument. Our findings provide a remarkable case in which a protein 
“moonlighting” function is found through evolution without functional selection.  
 
In Chapter 5, I summarize our current knowledge of the whole lipoate-protein ligase 
family. I describe my new findings about the true lipoic metabolism in mammalican cells 
(human and bovine) which havn’t been published yet in this chapter. I also explain a bit 
about that new group of proteins we found other than 2-oxoacid dehydrogenase and 
GcvH, but also requires binding of lipoic acid. 
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Figures 
 
Figure 1-1. Chemical structures of lipoic acid and related compounds. Lipoic acid is a 
derivative of octanoic acid where sulfur atoms are inserted at carbon 6 and 8. 
Dihydrolipoic acid is the reduced form of lipoic acid. 
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Figure 1-2. Lipoyl moieties. (A) The oxidized lipoate cofactor, lipoamide, bound to a 
highly conserved lysine residue of the E2 subunit of 2-oxoacid dehydrogenase or H 
protein of glycine cleavage complex. (B) the reduced form of the lipoate cofactor, 
dihydrolipoamide, bound to a conserved lysine residue of the E2 subunit or H protein of 
glycine cleavage complex. 
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Figure 1-3. Reactions of lipoylated complexes and structure of lipoyl domain (LD). (A) 
The general 2-oxoacid dehydrogenase reaction. In the first reaction step, the E1 subunit 
decarboxylates the α-ketoacid or acetoin substrate, and the acyl group is then 
transferred to lipoyl moiety located on the E2 subunit. The E2 subunit consecutively 
transfers the acyl group to coenzyme A (CoA). The lipoyl moiety is regenerated through 
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Figure 1-3 (cont.) reduction of NAD+ by the E3 subunit.  ThDP, thiamine diphosphate. (B) 
Glycine cleavage complex (GCV). GCV decarboxylates glycine to generate CO2, 
ammonia, and a methylene group that is transferred to the cofactor tetrahydrofolate for 
use in one-carbon metabolism. Note that serine hydrosymethyl transferase (SHMT) is 
not part of the GCV but allow serine auxotroph to grow on glycine. (C) Structure of the 
LD of Bacillus stearothemophilus PDH E2 subunit (PDB code 1LAB). Lipoic acid is 
bound at the tip of the protruding β-turn. 
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Figure 1-4. Lipoic acid synthesis and attachment in E. coli. When lipoic acid (LA) is 
present in the medium, LplA catalyzes the ligase reaction in two partial steps: the 
formation of lipoyl-adenylate, followed by transfer of the lipoate moiety to the acceptor 
protein (an LD or GcvH protein). When lipoic acid is absent, LipB, which is an octanoyl-
ACP transferase, transfers the octanoyl moiety from the fatty acid biosynthesis 
intermmideiate oncanoyl-ACP to an LD or GcvH. The octanoylated domains then 
become substrates for sulfur insertion by LipA at carbons 6 and 8.                                                       
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Figure 1-5. B. subtilis de novo lipoic acid synthesis. B. subtilis requires GcvH as an 
intermediate carrier. LipM transfers octanoyl moiety from ACP to GcvH, and then the 
octanoyl moiety is consecutively transferred to LD by LipL in a reversible reaction. Note 
that the lipoic acid scavenging pathway in B. subtilis is catalyzed by LplJ (figure not 
shown), which has the same mechanism as E. coli LplA. 
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Figure 1-6. Structure of E. coli LplA (PDB: 1X2H). The N-terminal large domain and C-
terminal small is annotated as in the picture. The glycine rich polypeptide linker 
connecting small and large domain is colored in red. 
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Figure 1-7. Threaded structural model of H. denitrificans LplA (magenta, KEGG entry 
Hden_0686) on the known structure of E. coli LplA (yellow, PDB: 1X2H). The structure 
of H. denitrificans LplA was made using SWISS-MODEL Workspace with automated 
mode. 
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Figure 1-8. (A), Structure of biotin. The pimeloyl-moiety is colored in blue and the 
synthesis of this part is quite diverse among biotin synthesis organisms, clearly differ 
between E. coli and B. subtilis. (B), Structure of biotinylated cognate protein. An amide 
bond is formed between the carboxyl end of biotin and ε-amino end of a highly 
conserved lysine residue on the cognate protein. Note that E. coli only has a single 
biotinylated protein, the AccB subunit of the essential enzyme, acetyl-CoA carboxylase 
whereas Salmonela enterica has a second one, the α subunit of oxaloacetate 
carboxylase (Wifling and Dimroth 1989, Woehlke, Wifling et al. 1992, Woehlke and 
Dimroth 1994).  
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CHAPTER 2 
THE STREPTOMYCES COELICOLOR LIPOATE-PROTEIN 
LIGASE IS A CIRCULARLY PERMUTED VERSION OF THE 
ESCHERICHIA COLI ENZYME COMPOSED OF DISCRETE 
INTERACTING DOMAINS 
Introduction 
 
Two different lipoate synthesis bacterial pathways have been described, the E. coli 
LipB-LipA pathway and a more complex lipoate relay pathway in B. subtilis that requires 
two additional proteins (Christensen, Martin et al. 2011, Martin, Christensen et al. 2011). 
Although the function and protein structure of the E. coli LplA lipoate ligase is well 
established (Morris, Reed et al. 1994, Morris, Reed et al. 1995, Hermes and Cronan 
2009, Fujiwara, Maita et al. 2010), the presence of this activity in other bacteria has 
been demonstrated only in B. subtilis where the ligase is called LplJ (Martin, 
Christensen et al. 2011) and in Listeria monocytogenes, a bacterium related to B. 
subtilis that is auxotrophic for lipoic acid and encodes two ligases both of which function 
in lipoic acid scavenging (Christensen, Hagar et al. 2011).  
 
Streptomyces coelicolor, like B. subtilis is a Gram-positive soil bacterium. This 
laboratory previously predicted that the putative lipoate protein ligase of this bacterium 
might have a circularly permuted architecture relative to the well-characterized E. coli 
LplA (Christensen and Cronan 2009).  Although the structurally characterized E. coli 
and Streptococcus pneumoniae LplAs have a large N-terminal domain that contains the 
lipoic acid binding site plus a small C-terminal domain (Figure 2-1) (Fujiwara, Maita et al. 
2010), in the S. coelicolor protein the small domain appeared to have been transposed 
to the N-terminus.  Another variation is seen in the mammalian lipoyl transferase which, 
although it shares 34% sequence identity with E. coli LplA and is slightly larger, is 
unable to synthesize the lipoyl-AMP intermediate. The mammalian protein functions 
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only to transfer the lipoyl moiety from the adenylate to the lipoate acceptor protein 
(Fujiwara, Takeuchi et al. 2001). A third type of lipoate ligase is found in the 
thermophilic archaeon Thermoplasma acidophilum where the ligase is composed of two 
separate proteins, LplA and LplB, encoded by adjacent genes (Kim, Kim et al. 2005, 
McManus, Luisi et al. 2006, Christensen and Cronan 2009, Posner, Upadhyay et al. 
2009, Posner, Upadhyay et al. 2013). Both LplA and LplB are required for lipoyl-
adenylate formation, but LplA alone is sufficient for lipoyl transferase activity 
(Christensen and Cronan 2009, Posner, Upadhyay et al. 2013).  A recent crystal 
structure shows that the two T. acidophilum proteins interact to form a structure having 
a domain orientation similar to that of the E. coli protein (Posner, Upadhyay et al. 2013).  
Given the low sequence identity with known ligases plus conservation of the E. coli 
domain arrangement even in an enzyme in which the arrangement is not dictated by 
covalent bonding, the question arises as to the whether or not the S. coelicolor protein 
is a functional LplA able to catalyze the overall ligase reaction.  Moreover, identification 
of a protein as encoding a lipoate protein ligase is not straightforward because 
members of this BPL_LplA_LipB protein family (Pfam Clan CL0040) catalyze three 
other reactions, octanoyl-transfer from octanoyl-ACP, amidotransfer in B. subtilis and 
ligation of biotin to its cognate proteins.  We report that the S. coelicolor protein is 
indeed a fully functional lipoate ligase and that when the two domains are separated 
into two polypeptide chains, the domains of S. coelicolor LplA interact and carry out 
both the lipoate activation and lipoyl transfer partial reactions. 
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Materials and Methods 
 
Chemicals, Bacterial Strains and Growth Media.  Antibiotics and most chemicals 
used in this paper were purchased from Sigma and Fisher, unless otherwise noted. 
American Radiolabeled Chemicals provided [α-32P]ATP. Oligonucleotide primers were 
synthesized by Integrated DNA Technologies and are shown in Table 1. PCR 
amplification was performed using Pfu polymerase (Stratagene) and Taq polymerase 
(New England Biolabs). Restriction enzymes and T4 DNA ligase were supplied by New 
England BioLabs. DNA sequencing was performed by AGCT. Invitrogen provided the 
Ni2-agarose column. Streptomyces coelicolor A3 genomic DNA was from a laboratory 
stock. Antibiotics were used at the following concentrations (in μg ml-1): sodium 
ampicillin, 100; kanamycin sulfate, 50; chloramphenicol, 40. L-Arabinose was used at a 
final concentration of 0.2%. The bacterial strains used were derivatives of E. coli K-12, 
(Table 1). The rich medium used for E. coli growth was Luria-Bertani broth (LB). 
  
Plasmid Constructions.  All the plasmids used and constructed in this paper are 
shown in Table 2-1. The S. ceolicolor lplA gene (SCO6423) was amplified by PCR from 
genomic DNA of strain A3 using Pfu DNA polymerase with primers XC001 and XC002 
that added BspHI and HindIII restriction sites. The product was digested with NcoI and 
HindIII restriction enzymes and ligated into pBAD322C downstream of an arabinose 
inducible promoter to give pXC001. The putative lplA gene was amplified in a similar 
manner as above using primers listed in Table 2-2 and inserted into the BamHI and 
XhoI sites of pET28b to express an N-terminal hexahistidine tagged protein. 
 
Plasmid pGS331 expressing E. coli E2 is under the control of tac promoter (Ali and 
Guest 1990, Ali, Moir et al. 1990). The lipoyl domain from S. coelicolor  branched-chain 
alpha-keto acid dehydrogenase E2 (SCO3815), S. coelicolor gcvH (SCO5471), and E. 
coli gcvH (b2904) were amplified by PCR from corresponding genomic DNAs with the 
primers XC005-XC010. All primers added BspHI and HindIII sites . The products were 
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digested with these restriction enzymes and ligated into pET28b to give plasmids 
pXC003-pXC005 listed in Table 2-1. Using the same approach, the large and small 
domains of S. coelicolor were inserted into plasmidspBAD322C and pKK223, 
respectively, using primers XC015-XC016 and XC017-XC018 to give pXC006 and 
pXC007. Using primers XC019-XC020, XC021-XC022 the two domains were also 
inserted into the pET28b vector to obtain pXC008 and pXC009. 
 
To obtain the circularly permutated S. coelilolor lplA gene, overlap extension PCR was 
performed. The large domain and the small domains of S. coelicolor lpA were first 
amplified by PCR using the primers XC025-XC024, primers XC016-XC023 (Table 2-2), 
respectively. The E. coli lplA linker sequence was added to primers XC023 and XC024 
to provide a spacer between the large and the small domains of the circularly 
permutated lplA gene from S. coelilolor. PCR products from the first round of  
amplification were purified using the QIAquick PCR Purification Kit (Qiagen). In the 
second round of PCR amplification, the purified large and small domain PCR products 
were used as templates and XC025, XC016 were used as primers to insert NcoI and 
HindIII sites. The final PCR product was digested with the same enzymes and inserted 
into pBAD322C digested with the same enzymes to give pXC010. All plasmids 
constructed were verified by DNA sequencing. 
 
Protein Expression and Purification.  The coding sequences of the wild type S. 
coelicolor lplA gene and its small and large domains were inserted into vector pET28b 
to generate pXC002, pXC008 and pXC009, respectively, to express N-terminal 
hexahistidine tagged proteins. Each plasmid was expressed in E. coli Tuner (BL21) 
strain. One liter cell cultures expressing the wild type LplA and small domain of LplA 
and four liter cultures of LplA large domain were grown at 37°C in LB medium until the 
OD600 reached 0.8 then induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) and allowed to grow for another 16 h at 18°C before harvesting. The cells were 
collected by centrifugation and resuspended in lysis buffer (50 mM sodium phosphate, 
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300 mM NaCl, 10 mM imidazole, 1 mM dithiothreitol, pH 7.4) and lysed by French 
Pressure cell treatment.  Cell debris was removed by centrifugation at 48,000xg for 40 
min. The supernatant was loaded on a nickel chelate resin (Qiagen) and allowed to bind 
to the resin for >five h. The column was washed with 10 column volumes of wash buffer 
(50 mM sodium phosphate, 300 mM NaCl, 50 mM imidazole, 1 mM dithiothreitol, pH 7.4) 
to remove contaminating proteins and the His-tagged protein was eluted with wash 
buffer but containing 200 mM imidazole). The protein was concentrated by ultrafiltration 
(Amicon Ultra 10 kDa or 3 kDa cut-off) and dialyzed overnight. Protein concentrations 
were determined at 280 nm using extinction coefficients calculated from the ProtParam 
program on the ExPASy Tools Website.  Protein purity was monitored by SDS-PAGE. 
 
Purification of Lipoyl Domain Substrates.  The E2 lipoyl domain and glycine 
cleavage H (GcvH) proteins of E. coli and S. coelicolor were purified by precipitation 
and ion exchange chromatography according to the methods described previously 
(Zhao, Miller et al. 2003). Plasmids pXC003, pXC004 and pXC005 all encoded the 
native proteins (Table 2-1). The anion exchange chromatography protocol allowed 
resolution of the apo and holo forms of the domain as shown on a 20% native PAGE gel. 
Pure apo domain was dialyzed, flash frozen in dry ice and stored in -80°C. The purified 
lipoyl domains were submitted to the University of Illinois at Urbana Champaign Mass 
Spectrometry Laboratory for electrospray mass spectral analysis. 
 
Complementation Analyses.  The E. coli ∆lipB ∆lplA strain QC146 was used for 
complementation. To prevent carryover of lipoic acid all plasmid carrying strains were 
grown for one day on the same medium containing 0.4% glycerol, appropriate 
antibiotics, 5 mM acetate and 5 mM succinate to bypass the lipoic acid requiring aerobic 
pathways. Strains were then grown at 37°C on M9 minimal plates, overnight with and 
without supplemented lipoic acid. Glycerol was used as an alternative carbon source in 
the absence of arabinose. 
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Western Blotting Analysis.  Strains MG1655, QC146, XC001, XC002 were grown to 
reach an OD600 of 0.8 in 20 ml of LB medium with additional lipoic acid (5 μg/ml) and 
arabinose (0.2%). Soluble fractions of whole cell extracts were analyzed by SDS-PAGE. 
Equal amount of protein were loaded and separated on a 12% SDS-PAGE gel and 
electrophoretically transferred to Immobilon-P membranes (Millipore) for 15 min at 15V. 
The membranes were pre-blocked with TBS buffer (100 mM Tris Base, 0.9% NaCl, pH 
7.5) containing 0.1% Tween 20 and 5% nonfat milk powder. The membranes were 
probed for 1 h with an anti-lipoyl protein primary antibody from Calbiochem diluted 
1:10,000 in the above buffer. Following incubation with a secondary goat anti-rabbit 
antibody from Roche (1:5000), the labeled proteins (PDH and OGDH) were detected 
using Quantity One software. 
 
Structural Modeling and Sequence Alignment.  A model of the small domain of S. 
coelicolor LplA was determined by threading it to  T.acidophium LplB crystal structure 
(PDB 3R07, chain C) using the automated mode of Swiss-Model(Peitsch 1996, Arnold, 
Bordoli et al. 2006, Kiefer, Arnold et al. 2009). The S. coelicolor LplA large domain was 
likewise threaded using T.acidophium LplA (Protein Data Bank code 3R07, chain A) as 
template. The final image was generated using UCSF Chimera package(Pettersen, 
Goddard et al. 2004). The sequence alignment was conducted using ClustalW2 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html), and the final output shown in Figure 
2-3 and Figure 2-5 was created by ESPript.3.0 (http://espript.ibcp.fr/ESPript/cgi-
bin/ESPript.cgi). 
 
Gel Shift Assay for Lipoyl Domain Modification Analysis.  A 20 μl reaction mixture 
contained 50 mM sodium phosphate buffer (pH 7.0), 1 mM sodium lipoate, 5 mM 
disodium ATP, 5 mM dithiothreitol, 1 mM MgCl2, and 20 μM apo-lipoyl domain (or apo-
GcvH). 2 μM of S. coelicolor small domain and 4 μM of the large domain  were added 
as indicated in Figure 2-8. The reactions (20 μl) were incubated at 37°C for 4 h and 
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loaded on a 15% native polyacrylamide gel containing 2.5 M urea and separated by 
electrophoresis. 
 
Lipoyl-AMP was chemically synthesized according to the method of Reed et al (Reed, 
Koike et al. 1958). The product was confirmed by mass spectral analysis performed by 
University of Illinois at Urbana Champaign Mass Spectrometry Laboratory. Lipoyl-AMP 
was dissolved in 100 mM sodium phosphate buffer (pH 7.0). The reaction (20 μl)  
contained the following components: 50 mM sodium phosphate buffer (pH 7.0), 1 mM 
tris (2-carboxyethyl) phosphine, 5 mM dithiothreitol, 0.1 mM MgCl2, and 20 μM apo-LD 
of S. coelicolor and 1 mM synthetic lipoyl-AMP, 2 μM small domain, 4 μM large domain 
or 2 μM of wild type S. coelicolor LplA. Gel shift assay to analyze S. coelicolor LD 
modification was performed as described above after incubation of the reaction at 37°C 
for 4 h.  
 
Mass Spectrometry of Lipoyl Domains.  The reaction mixtures (100 μL) contained 50 
mM sodium phosphate buffer (pH 7.0), 1 mM sodium lipoate, 5 mM disodium ATP, 5 
mM dithiothreitol, 1 mM MgCl2, 20 μM apo-LD , with or without 2 μM wild type S. 
coelicolor LplA was incubated at 37°C for 4 h as indicated. The reactions were dialysed 
overnight against 200 mM ammonium acetate buffer and dried the next day under a 
nitrogen stream. Samples were submitted to University of Illinois at Urbana Champaign 
Mass Spectrometry Laboratory for electrospray mass spectrometric analysis. 
 
Assay of Enzymatic Lipoyl-AMP Intermediate Formation.  The reactions contained 
50 mM sodium phosphate buffer (pH 7.0), 1 mM tris (2-carboxyethyl) phosphine, 10 nM 
[α-32P]ATP, 10 μM MgCl2, 0.1mM sodium lipoate. 20 μM (or 10 μM) apo-LD as acceptor 
protein, 20 μM (or 10 μM) small domain, 8 μM (or 4 μM) large domain and 2 μM of wild 
type S. coelicolor LplA as indicated in Figure 8. The reaction was incubated for 1 hour at 
37°C. 1 μl of each reaction mixture was spotted on cellulose thin-layer chromatography 
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(TLC) plates and developed in isobutyric acid-NH4OH-water (66:1:33). The TLC plates 
were dried overnight and exposed to a phosphorimaging plate and visualized using a 
Fujifilm FLA-3000. 
  
Bioinformatics and Phylogenetic Analysis. The amino acid residue sequences of 
different species were retrived from the BLAST page of the ExPAsy server using Swiss-
Prot+TrEMBL+TrEMBL_NEW method (www.expasy.ch/tools/blast) (Dereeper, Guignon 
et al. 2008, Dereeper, Audic et al. 2010). Both the number of best scoring sequences 
and the number of best alignments were set to 1000. The e-values of the sequences 
selected were between 10-40 and 10-5. Mutiple sequence alignments was by ClustalW. 
Gap rich columns were ignored (Castresana 2000). The poorly conserved N-termini and 
C-termini were removed. The phylogenetic tree was constructed using the maximum 
likelihood method with PhyMl program through website atgc.lirmm.fr/phyml (Guindon 
and Gascuel 2003, Chevenet, Brun et al. 2006). The alignment used is Phyllips 
Interleaved. Bootstrap analysis was set to 1000 replicates. 
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Results 
 
The Putative S. coelicolor LplA is a bona fide lipoate protein ligase. The amino 
acid sequence of the putative S. coelicolor LplA shares only marginal sequence identity 
(~15%) with E. coli LplA and the other lipoate ligases of known activity. To test if the S. 
coelicolor protein has LplA activity we first tested its ability to restore growth of the E. 
coli ∆lipB ∆lplA strain QC146 (Christensen and Cronan 2009).  The ∆lipB and  ∆lplA 
deletions of this strain results in an inability to synthesize lipoate or to scavenge lipoic 
acid from the medium (Morris, Reed et al. 1995, Christensen and Cronan 2009). The 
putative lplA gene S. coelicolor was inserted into the arabinose-inducible vector 
pBAD322C and transformed into strain QC146.  Complementation was tested on M9 
minimum agar plates with glycerol as sole carbon source to avoid bypass of succinate 
and acetate-dependent growth by fermentative metabolism (Herbert and Guest 1968). E. 
coli strain QC146 is unable to grown on this medium with lipoic acid supplementation.  
However growth proceeds robustly when a plasmid encoding lipoate ligase activity is 
present. Upon expression of the gene expressing the putative S. coelicolor lplA, the E. 
coli strain grew well, but only when the medium contained lipoic acid (Figure 2-2). 
Growth proceeded either in the presence or absence of arabinose.  Growth in the 
absence of arabinose suggested that only low levels of the S. coelicolor protein were 
required to catalyze attachment of exogenous lipoic acid to the 2-oxoacid 
dehydrogenases of E. coli.  
 
To characterize the function of S. coelicolor LplA in vitro, we purified the protein to 
homogeneity (Experimental Procedures) (Figure 2-3C). The ligation activity of the 
protein was tested in vitro with E2 LD and GcvH proteins from both E. coli and S. 
coelicolor as acceptor proteins (Figures 2-4 & 2-5). The use of E2 LDs allows detection 
of modification by gel shift assays and electrospray mass spectrometry. We found that 
in the presence of lipoic acid and ATP, the E2 LD was modified as shown by the more 
rapid migration of the protein in native gel electrophoresis due to loss of the lysine 
positive charge upon modification (Figure 2-4A).  Electrospray mass spectrometry 
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further confirmed that the molecular weight of the modified E2 LD was that of the lipoyl 
domain (Figure 2-4B). The GcvH proteins are slightly larger than E2 LD and their 
modification could not be distinguished on native gels. Thus [1-14C]octanoic acid, a 
substrate of E. coli LplA in vivo and in vitro (Morris, Reed et al. 1994, Zhao, Miller et al. 
2003) was used in place of lipoic acid.  S. coelicolor LplA modified the GcvH proteins of 
both E. coli and S. coelicolor although the native protein seemed a better substrate 
(Figure 2-5C). These data demonstrate that despite its atypical domain arrangement 
and its low sequence similarity to the documented lipoate ligases, S. coelicolor LplA is a 
fully functional lipoate ligase. 
 
The S. coelicolor LplA retains function when its domain architecture is altered to 
that of E. coli LplA.  The finding that the separate proteins of the T. acidophilum ligase 
interact to form a structure having the same domain orientation as that of the E. coli 
ligase argued that restructuring the domain orientation of S. coelicolor LplA into that of E. 
coli might result in an inactive protein. To test this argument  we constructed a circularly 
permuted version of the S. coelicolor LplA having the domain orientation of E. coli LplA.  
Construction of circularly permuted proteins requires cleavage of the native sequence 
without perturbation of the domain structures and covalent linking of the original N- and 
C-termini without untoward disturbance of the structure (Figure 2-6A). Since the 
structure of S. coelicolor LplA was unknown, the first challenge was to find an 
appropriate junction between the small and large domains. Swiss Model Workspace 
was used to construct a model of S. coelicolor LplA using the T. acidophilum LplA-LplB 
structure (Posner, Upadhyay et al. 2013) as template. Several candidate cleavage 
positions were chosen and tested. The next challenge was to find a proper linker to fuse 
the two domains in their new orientation. For this purpose we utilized the inter-domain 
linker of E. coli LplA, an 8 residue segment of sequence FGQAPAFS that orients the 
two domains to form a substrate binding pocket in the lipoate activation step and plays a 
role in rotation of the small domain in the lipoyl moiety transfer step (Fujiwara, Maita et 
al. 2010). 
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We inserted the genes encoding the circularly permuted proteins into the pBAD322C 
vector and tested complementation of E. coli strain QC146 as above. Only one of the 
three constructs allowed growth, the least truncated construct having the cleavage 
position between residues H126 and A127. The rearranged S. coelicolor LplA shared 
had <20% identity with E. coli LplA. To test the enzymatic activity of this protein in vitro, 
we purified the N-terminal hexahistidine tagged protein by nickel chelate 
chromatography.  Unfortunately the protein showed no detectable activity in vitro in 
either the gel shift or radioactive assays. Several other constructs encoding proteins 
having cleavable and C-terminal hexahistidine tags were made, but all failed to show 
detectable in vitro activity.  The difference in the in vivo and in vitro results is readily 
explained by the greater sensitivity of the in vivo assay.  Only trace amounts  of lipoic 
acid are required for growth of E. coli (Herbert and Guest 1968). Indeed western blotting 
analysis of cell extracts with anti-lipoic acid antibody showed low levels of lipoylation in 
strain QC164 expressing the circularly permuted LplA (Figure 2-6C).  A protein band of 
lipoylated 2-oxoglutarate dehydrogenase E2 was readily seen whereas the lipoylated 
pyruvate dehydrogenase E2 band was faint (Figure 2-6C). The faint pyruvate 
dehydrogenase band is due to the presence of three lipoyl domains on the E2 protein 
which causes the protein to run in abnormally diffuse bands on SDS gels (only one of 
the three domains is required for enzyme activity) (Guest, Lewis et al. 1985, Morris, 
Reed et al. 1994).  Therefore, the complementation data were confirmed by the western 
blotting results. 
 
Both the large and small domains are required for activating lipoate to lipoyl-AMP 
whereas only the large domain is required for lipoyl transfer activity.  The success 
of the circular permutation arrangement argued that perhaps the interactions between 
the two domains of the S. coelicolor LplA were sufficiently strong that the enzyme might 
functional when the two domains were separate protein molecules as is the case in the 
enzyme from the archaeon, T. acidophilum.  By use of the same cleavage site used to 
make the permuted construct we separated the domains in silico and threaded the 
structure of the large and small domains using the Swiss Model Work Space on the 
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structures of LplA and LplB of T. acidophilum, respectively (Figure 2-6B). Despite the 
low sequence identities between the two ligases, threading was successful. The 
subgenes encoding the S. coelicolor LplA small and large domains were inserted into 
vectors pBAD322C and pKK223, respectively. Complementation of the E. coli lipoate 
auxotrophic strain QC164 showed that the strain grew well when both plasmids were 
present, whereas strain QC164 expressing either plasmid alone failed to grow (Figure 
2-7). This indicated that both domains were required for the overall lipoylation reaction. 
In order to test which domain(s) were required for each partial reaction we purified the 
two domains using N-terminal hexahistidine tags. Purification of the large domain was 
problematical due to precipitation of the protein. After several protocols were tried Ni ion 
-affinity chromatography followed by size exclusion chromatography gave modest 
amounts of soluble protein (Figure 2-8A). The overall lipoylation activity was tested by 
the gel shift assay with the S. coelicolor LD as the acceptor protein (data not shown) 
and by mass spectral analysis (Figure 2-8B). LD modification was only seen when both 
domains were present.  To test the first step of the enzyme reaction, activation of lipoic 
acid with ATP to form lipoyl-AMP, [α-32P]ATP was used as substrate.  The reaction 
products were analyzed by cellulose thin layer chromatography and visualized by 
phosphorimaging. In this system lipoyl-AMP is the most rapidly migrating spot (Figure 2-
8C). When wild type S. coelicolor LplA was assayed in the absence of LD lipoyl-AMP 
was formed.  Based on prior results with various lipoate and biotin ligases we expected 
that most of the lipoyl-AMP would remain stably bound within the active site thus limiting 
the amount of product formed.  Indeed, this seems the case because upon addition of 
the LD acceptor protein, the accumulation of the other product, AMP, markedly 
increased due to transfer of lipoyl group from lipoyl- AMP to the LD.  Most important, 
lipoyl-AMP was only formed when both of the domain proteins were present and thus 
both domains were required for lipoate activation. Finally we tested the role of each 
domain in the second step, transfer of the lipoyl moiety to the LD, by use of chemically 
synthesized lipoyl-AMP as substrate.  Gel shift assays (Figure 2-8D) indicated that lipoyl 
domain modification required only the large domain of S. coelicolor LplA.  
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The conserved GDFF is not significant in S. coelicolor LplA domain interactions. 
Previous studies in our lab found that in the lipoate ligase family, the small domain 
contains a highly conserved GDFF motif (Christensen and Cronan 2009), in which the 
aspartate residue is best conserved. In E. coli, the Asp residue faces the catalytic 
domain and is in close proximity to the loop formed by residues 69-76 (Fujiwara, Maita 
et al. 2010), which are the highly conserved residues forming active site of binding 
lipoate in the catalytic domain. We substituted several different residues (A, K, R) for 
residue Asp66 of the S. coelicolor LplA small domain. Growth curves showed that the 
mutation reduced the rate of exponential growth of the E. coli lipoate auxotroph strain 
QC146, but mutant strains continued growth and reached the same final cell density 
(data not shown). Thus the conserved Asp residue plays only a modest role in enzyme 
activity.  This is consistent with the large number of interactions between the large and 
small subunits seem in the T. acidophilum ligase structure (Posner, Upadhyay et al. 
2013). 
 
Bioinformatic Analysis of S. coelicolor LplA.  A phylogenetic tree was constructed 
using the maximum likelihood method. The phylogeny of S. coelicolor LplA with the 
circularly permutated architecture was determined with other LplA homologues (Figure 
2-9). The E. coli  LplA with the C-terminal small domain and the mammalian (B. taurus) 
lipoyltransferase which has a small domain of unknown function were included as an 
outgroup. This analysis revealed that the S. coelicolor LplA homologues form a close 
clade with other Actinomyces. Interestingly, some strains of Rhizobiales and 
Burkholderiales have proteins that are highly similar identity to that of S. coelicolor 
although bacteria these have a remote evolutionary ancestry.  
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Discussion 
 
The PfamA biotin/lipoate A/B protein ligase family includes both classical ligases and 
other enzymes catalyzing acyl transfer.  The classical ligases (those that produce AMP) 
seemed to have a consistent overall architecture: a large N-terminal domain and a small 
C-terminal domain.  This architecture persisted even when the domains resided in 
separate proteins as in the T. acidophilum lipoate ligase.  However this “rule” has now 
been broken by the demonstration that a ligase having the opposite architecture, the S. 
coelicolor LplA, is fully functional.  Moreover, the S. coelicolor enzyme retains some 
activity when it is manipulated into the classical ligase architecture and functions when 
the two domains are divided into separate proteins.  Among the classical ligases of this 
family S. coelicolor LplA stands out.  The bacterial biotin ligases have a large N-terminal 
domain and a small C-terminal domain.  The catalytic region of the eukaryotic biotin 
ligases follow the same architecture although these enzymes have very large and 
variable N-terminal extensions which double the size of the proteins and function in 
binding of the acceptor substrate. Thus far, no example of a bipartite biotin ligase has 
been reported and thus the interesting notion that, in analogy to LplA, the C-terminal 
domain of the biotin enzymes is required for biotin-adenylate synthesis but not for biotin 
transfer has not been tested. 
 
The most curious of the lipoate ligase family proteins are the human and bovine 
lipoyltransferases which are unable to perform the first partial reaction, synthesis of the 
adenylate . The large domains of the mammalian lipoyltransferases and E. coli LplA 
share about 30% identity whereas the small domains show few identical residues. In the 
lipoate activation partial reaction the small domain of E. coli LplA moves toward the 
large domain to form the lipoic acid binding pocket whereas in the second partial 
reaction, the small domain rotates away from the large domain about 180° (Fujiwara, 
Maita et al. 2010).  In contrast the small domain of the bovine lipoyltransferase is always 
extended and the β12-α6 region dynamically moves to the ligand side and forms an 
adenylate binding loop (Fujiwara, Hosaka et al. 2007). However, in the E. coli LplA 
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structure, the loop equivalent to the adenylate binding loop is disordered because of 
steric hindrance caused by the altered conformation of the small domain (Fujiwara, 
Maita et al. 2010).  Despite these differences we tested if the presence of the S. 
coelicolor small domain would permit lipoate activation by the human lipoyltransferase 
large domain.  This was tested both as separate domains and by fusing the two 
domains using the E. coli LplA interdomain linker (as in the reverse S. ceolicolor 
construct).  We also fused the E. coli small domain to the human lipoyltransferase large 
domain at a triplet sequence (WDW) conserved in both proteins that is located within a 
highly conserved region close to the ends of both large domain sequences.  None of 
these constructs allowed growth of the E. coli lipoate auxotroph strain QC146.  Note 
that adenylate synthesis has been ascribed to a mitochondrial medium chain acyl-CoA 
synthetase known as ACSM1 34, 35.  This is an enzyme of broad acyl chain specifity 
including several xenobiotics that contains each of the motifs of this well studied 
enzyme family (Fujino, Takei et al. 2001, Vessey, Lau et al. 2003).  However, ACSM1 is 
reported to convert both the natural (R)- and unnatural (S)-lipoate isomers to their 
adenylates and also uses GTP to produce lipoyl-guanylate which is released from the 
enzyme to serve as a lipoyltransferase substrate (Fujiwara, Takeuchi et al. 2001).  
Moreover, ACSM1 can use GTP only to activate lipoate, acyl-CoA synthesis requires 
ATP (Fujiwara, Takeuchi et al. 2001).  From these considerations we believe it unlikely 
that ACSM1 acts in lipoate metabolism. 
 
The lipoate protein ligase subfamily does not have a defined organization. Thus far, all 
have two domains but the small domain can be located on either the side of the large 
domain or on separate proteins as in the Thermoplasma acidophilum lipoate ligase. 
Some LplA-related proteins lack a small domain such as LipB, which is responsible for 
transferring the endogenously synthesized octanoic acid from ACP to the lipoate 
dependent acceptor proteins.  It currently seems that “short” LplA homologues are likely 
to be octanoyl transferases rather than ligases, but the diverse structures of lipoate 
ligases must be kept in mind.  
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It should be noted that the Ting group has converted E. coli LplA into a very useful 
reagent for protein labeling with diverse fluorophores.  This was done by substituting 
other residues for residue W37 which is located at the end of the lipoic acid binding 
pocket and acts as a “gate-keeper” residue. The mutations enlarge the active site 
volume and allow binding of substrates of smaller size and different shapes relative to 
lipoic acid(Baruah, Puthenveetil et al. 2008, Uttamapinant, White et al. 2010, Cohen, 
Zou et al. 2012). However, some molecules are not utilized by LplA although they are of 
smaller size than lipoate (Baruah, Puthenveetil et al. 2008).  The structural diversity of 
lipoate ligases may allow a wider range of substrates to be utilized as protein labeling 
tools.  A crystal structure of S. coelicolor LplA might be valuable in this regard. 
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Tables 
Table 2-1. Bacterial Strains and Plasmids Used in Chapter 2 
Strains              Relevant  Genotype or Description             Reference or Derivation                    
E. coli 
MG1655                 E. coli K-12 wild type                                                   Lab stock              
DH5α                      ∆(argF-lacZ)U169 Ф80 ∆(lacZ)M15 recA1 endA1      Lab stock 
Tuner                      ompT hsdSB(rB–mB–) lacY1                                      Novagen 
QC146                    ∆lipB ∆lplA of MG1655                                                                13 
XC001                     QC146 carrying pXC001                                          This study                                   
XC002                     QC146 carrying pXC010                                          This study                                                                      
 
Plasmids 
Plasmid                                                              Relevant Genotype or Description Reference or 
Derivation 
pET28b                     T7 promoter expression vector, KanR Novagen 
pBAD322C                       Low copy expression vector, CmR (Fujino, Takei et 
al. 2001) 
pXC001 pBAD322C encoding S. coelicolor LplA This study 
pXC002 pET28b encoding N-terminal hexahistidine tagged S. 
coelicolor LplA 
This study 
pGS331                 E. coli E2 lipoyl domain  (Ali and Guest 
1990) 
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Table 2-1 (cont.) 
pXC003 pET28b encoding native S. coelicolor E2 lipoyl domain This study 
pXC004 pET28b encoding native S. coelicolor GcvH This study 
pXC005                      pET28b encoding native E.coli GcvH This study 
pXC006 pBAD322C encoding S.coelicolor LplA small domain This study 
pXC007 pKK223 encoding S.coelicolor LplA large domain This study 
pXC008 pET28 encoding N- terminal  hexahistidine tagged 
small domain of S. coelicolor LplA 
This study 
pXC009 pET28 encoding N- terminal  hexahistidine tagged 
large domain of S. coelicolor LplA 
This study 
pXC010 pBAD322C encoding circularly permutated S. 
coelicolor LplA 
This study 
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Table 2-2. Oligonucleotides (5’-3’) Used in Chapter 2  
XC001 LplA F BspHI ATATTGCTCATGACCGCCCGGACGGGGG  
XC002 LplA R HindIII ATCAAGCTTTCAGGGCACCCGGGCG  
XC003 LplA F BamHI TCAGGATCCGGTGACCGCCCGGACGGG  
XC004 LplA R Xhol GCCTCGAGTCAGGGCACCCGGGCGGTCCAC  
XC005 S. coelicolor E2 LD F 
BspHI 
TTCA CCATGGAGTTCAAGCTGCCCGACCT  
XC006 S. coelicolor E2 LD R 
HindIII 
ATTAAAGCTTACTCGGTGCCCTCCTCGC  
XC007 S. coelicolor GcvH F BspHI ATATTTCATGAGCAACCCCCAGCAGCT  
XC008 S. coelicolor GcvH R 
HindIII 
TATTAAGCTTCAGGCGCCGGCGAAGGC  
XC009 E. coli GcvH F BspHI GCTTCATGAGCAACGTACCAGCAGAAC  
XC010 E. coli GcvH R HindIII ATCAAGCTTACTCGTCTTCTAACAATGCT  
XC015 Small domain F BspHI ATATTGCTCATGACCGCCCGGACGGGGG  
XC016 Small domain R HindIII ATCAAGCTTTCAGTGCGCCAGCGCGCG  
XC017 Large domain F EcoRI TATTCCGAATTCATGGCCACGGACTGGACGG
AC 
 
XC018 Large domain R PstI AATCTCTGCAG TCAGGGCACCCGGGC  
XC019 Small domain F NdeI ATATCC CATATGACCGCCCGGACGGG  
XC020 Small domain R XhoI ACTACTCGAGTCAGTGCGCCAGCGCGCG  
XC021 Large domain F NdeI ATATCCCATATGGCCACGGACTGGACG  
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Table 2-2 (cont.)   
XC022 large domain R xhoI GACTACTCGAGTCAGGGCACCCGGGC  
XC023 Small domain F with 
E. coli Linker 
TTCGGTCAGGCTCCGGCATTCTCG 
GTGACCGCCCGGACGGGG 
 
XC024 Large domain R with 
E. coli Linker 
CGAGAATGCCGGAGCCTGACCGAAGGGCAC
CCGGGCGGTCCACT 
 
XC025 Large domain F NcoI ATACTACCATGGCCACGGACTGGACG  
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Figures 
 
 
Figure 2-1, Lipoate-protein ligase (LplA) domain architecture. Different arrangements of 
coding sequences and domains found in E. coli LplA, the putative S. coelicolor enzyme, 
and the T. acidophilum bipartite ligase. 
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Figure 2-2, Expression of the S. coelicolor protein complements growth of the E. coli 
∆lipB ∆lplA strain QC146. Strain QC146 was transformed with a pBAD322C-derived 
plasmid that expressed S. coelicolor LplA from an arabinose inducible promoter. The 
control strains are the wild type (WT) strain and strain QC146 containing the empty 
vector (pBAD322C).  Complementation proceeded both in the presence and absence of 
arabinose induction.  The plates above lacked arabinose. 
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Figure 2-3. Sequence alignments of lipoyl domain (LD) and purification of S. coelicolor 
LplA. (A) Sequence alignment of a lipoyl domains (LD) of E. coli pyruvate 
dehydrogenase E2 component (locus tag b0115) and the S. coelicolor branched-chain 
2-oxo acid dehydrogenase E2 component (SCO3815).  Conserved residues are in white 
text on a red background and similar residues are in red text and boxed in blue. The E. 
coli LD secondary structure (PDB: 1QJO) is shown at the top of the panel. β: β sheet; T: 
β turns/coils.  (B) Threaded structural model of LD73_SC (in magenta) on the known 
structure of LD71_EC (in green).  (C) Purification of S. coelicolor LplA.  M denotes the 
molecular weight of Pre-Stained Broad Range Protein standards (Bio-Rad).  The protein 
was purified as described in Experimental Procedures and analyzed by SDS-
electrophoresis on a 15% polyacrylamide gel.   
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Figure 2-4. In vitro lipoylation catalyzed by S. coelicolor LplA using lipoyl domains as 
acceptors. (A) Lipoylation activity of S. coelicolor LplA with LD71_EC and LD73_SC 
(Figure 3), measured by the gel shift assay. The loss of the positive charge of the 
modified lysine ε-amino group of the lipoyl domain results in of the modified form faster 
migration on native gels. Lane designations given in parentheses are the same in the 
two panels. Lane 1, no enzyme (NE); lane 2, enzyme LplA added (LplA). Left gel: 
Modification of the E. coli pyruvate dehydrogenase lipoyl domain LD71_EC by lipoate 
attachment. Right gel: Modification of S. coelicolor  branched-chain 2-oxoacid 
dehydrogenase lipoyl domain LD73_SC. (B) Electrospray mass spectrometry analysis 
of the unmodified (calculated mass of 7708.9) and (C) lipoylated (calculated mass of 
7896.9) forms of LD73_SC.  
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Figure 2-5.  In vitro lipoylation catalyzed by S. coelicolor LplA using GcvH as acceptor 
proteins. (A) Sequence alignments of the GcvH proteins of E. coli and S. coelicolor. (B) 
Model of S. coelicolor GcvH (orange) obtained by threading on the E. coli GcvH 
structure (PDB 3A7L, green) and (C) Activity of S. coelilolor LplA on the two various 
GcvH proteins.  [1-14C]Octanoic acid was used as substrate. The [1-14C]octanoyl-GcvH 
proteins are indicated by the arrow. Lanes 1 and 2, E. coli GcvH. Lanes 3 and 4, S. 
coelicolor GcvH. Lane 5, E. coli LD71_EC as positive control. 
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Figure 2-6. Construction of the circularly permutated S. coelicolor LplA and its in vivo 
lipoylation activity. (A) Scheme for the construction of the circularly permutated S. 
coelicolor LplA. The two PCR-generated fragments encoding the large domain and 
small domains were ligated into the expression vector pBAD322C. (B) Models of the 
large (right structure) and small (left structure) domains of S. coelicolor LplA threaded 
on the corresponding proteins of T. acidophilum (PDB 3R07). (C) Western blot analyses 
of protein lipoylation in vivo. E. coli strains were grown in LB medium supplemented with 
lipoic acid. Equal amounts of total cell extract protein were loaded into each lane of an 
SDS-PAGE gel, transferred to Immobilon P and subjected to immunoblotting with anti-
lipoic acid antibody. The samples were loaded in duplicate in adjacent lanes. Lanes 1 
and 2, the wild type E. coli strain MG1655 expressing both LplA and LipB. Lanes 3 and 
4, strain QC146 (∆lplA ∆lipB) expressing S. coelicolor LplA. Lanes 5 and 6, strain 
QC146 (∆lplA ∆lipB) expressing the circularly permutated S coelicolor LplA.  Lanes 7 
and 8, strain QC146 (∆lplA ∆lipB) transformed with empty vector pBAD322C.  
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Figure 2-7. Lipoylation activity of the individual separated domains of S. coelicolor LplA. 
The E. coli ∆lipB ∆lplA strain QC146 was transformed with a plasmid encoding the small 
domain and/or a second plasmid encoding the large domain. Wild type MG1655 was 
used as control strain.  
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Figure 2-8. Purification of the small and large domains of S. coelicolor LplA and the 
enzymatic role of each domain. (A) SDS-PAGE profile of the purified small domain and 
large domain of S. coelicolor LplA.  Lane 1: Small domain (13 KD). Lane 2, large 
domain (29 KD). (B) Electrospray mass spectrometric analysis of lipoylated LD73_SC 
(calculated mass of 7896.5) produced by a mixture of the separately expressed and 
purified S. coelicolor small and large domain proteins. (C) Thin layer chromatographic 
analysis of products formed from α-labeled 32P-ATP.  Ligase activity was assayed using 
different forms of S. coelicolor LplA. Both synthesis of lipoyl-5’-AMP and transfer of the 
lipoyl moiety to the LD73_SC acceptor protein, are shown. Lanes with “++” denote that 
the concentration of enzymes added is twice than that of lanes with “+”.  (D) Transfer of 
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Figure 2-8 (cont.) lipoyl moiety from synthetic lipoyl-AMP assayed by the gel shift assay. 
Lane 1, Apo lipoyl domain LD73_SC. Lane 2, Holo lipoyl domain LD_73SC. lanes 3 and 
4, only small domain was added. Lanes 5 and 6, only large domain was added. Lanes 7 
and 8, both domains were added.  Note that transfer to the acceptor protein results in 
an increase in AMP production. 
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Figure 2-9. Phylogenetic tree of lipoate protein ligases of the Actinomycetes. 
The tree is draw to scale. The branch lengths are in the same units as the evolutionary 
distances. The E. coli LplA and B. taurus lipoyl transferase were used as the related 
out-group. 
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CHAPTER 3  
EXPRESSION AND ACTIVITY OF THE BIOH ESTERASE OF 
BIOTIN SYNTHESIS IS INDEPENDENT OF GENOME 
CONTEXT 
  
Introduction 
The biotin synthesis pathway can be readily divided into early and late stages. The 
enzymes of the late stage, those required for the assembly of the two heterocyclic rings, 
are strongly conserved across the archea, bacteria, plants and fungi and their 
biochemistry and structures are well understood. In E. coli and many other bacteria 
these steps are encoded in a gene cluster which often is regulated by BirA, a 
bifunctional protein that acts both as a biotin-protein ligase and a transcriptional 
repressor (Barker and Campbell 1981, Barker and Campbell 1981). In contrast the early 
stage, that responsible for synthesis of the pimelate thioester that contributes to the 
valeric side chain and the first ring carbons, is quite diverse. The pathway for synthesis 
of this moiety was demonstrated only recently in E. coli and consists of enzymes 
encoded by the bioH and bioC genes that allow the fatty acid synthesis pathway to 
make pimelate, a seven carbon dicarboxylic acid (Lin, Hanson et al. 2010, Lin and 
Cronan 2011) (Fig. 3-1A). BioC, a carboxyl methyltransferase, initiates biotin synthesis 
by methylation of the free carboxyl group of a fraction of the key fatty acid synthetic 
intermediate, malonyl-ACP and thereby appropriates a small portion of malonyl-acyl 
carrier protein (ACP) from the type II fatty acid synthesis pathway (Fig. 3-1A). 
Methylation of the free carboxyl of malonyl-ACP disguises the substrate and allows its 
entry into the fatty acid synthesis pathway (Lin, Hanson et al. 2010, Lin and Cronan 
2011). When the acyl chain has been elongated to seven carbons, the disguise is (and 
must be) removed by the BioH pimeloyl-ACP methyl ester esterase (Lin, Hanson et al. 
2010). A remaining puzzle in the E. coli pathway is that BioC is encoded within the 
bioABFCD operon at min 17 of the genome and is transcriptionally regulated with the 
other operon genes by the BirA repressor/biotin protein ligase. In contrast the bioH gene 
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is encoded at a distant location and is not regulated by BirA (Fig. 3-1B) (Barker and 
Campbell 1980, N Koga, Kishimoto et al. 1996). However, in other proteobacteria (e.g., 
the pseudomonads) the bioH gene is found within a putative biotin operon where it is 
generally located immediately upstream of bioC (Fig. 3-1B) (Rodionov, Mironov et al. 
2002). E. coli BioH is known to be a rather promiscuous carboxylesterase in that it 
hydrolyzes the ester bonds of short and medium acyl chain p-nitrophenyl esters 
(Sanishvili, Yakunin et al. 2003, Kwon, Kim et al. 2009) and also cleaves the ethyl, 
propyl and butyl esters of pimeloyl-ACP (Christensen and Cronan 2010). Others have 
reported that BioH cleaves the methyl ester of dimethylbutyryl-S-methyl 
mercaptopropionate (Xie, Wong et al. 2007) and like other esterases can catalyze 
condensation reactions in organic solvents (Jiang, Wang et al. 2014, Jiang and Yu 2014, 
Jiang and Yu 2014). BioH is also an atypical biotin synthetic enzyme in that in many 
bacteria it is functionally replaced by other nonorthologous esterases of very different 
sequence (Rodionov, Mironov et al. 2002).  To date BioG most often replaces BioH 
although several other nonorthologous BioH substitutes have been described that, 
unlike BioH and BioG, are restricted to very specific bacterial species. Examples are 
BioK in cyanobacteria (Rodionov, Mironov et al. 2002), BioV in Helicobacter species (Bi, 
Zhu et al. 2016) and BioJ in Francisella species (Feng, Napier et al. 2014).  This 
unexpected diversity argues that some of the enzymes that cleave the methyl ester of 
pimeloyl-ACP methyl ester may have arisen recently and hence may not be attuned to 
the low demands of biotin synthesis (E. coli growth requires only a few hundred biotin 
molecules per cell).  Indeed, E. coli BioH is a much better catalyst by orders of 
magnitude than the later enzymes of the pathway BioA, BioB and BioD (Alexeev, Baxter 
et al. 1995, Webster, Alexeev et al. 2000, Eliot, Sandmark et al. 2002, Farrar, Siu et al. 
2010).   
 
Given this situation we hypothesized that the BioH proteins encoded within an operon 
(“operon-encoded”) may be better attuned to the later enzymes in the pathway than the 
“freestanding” BioH proteins. This is because their expression would be regulated at the 
transcriptional level and hence coordinated with expression of the other enzymes. 
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Moreover, expression might also be coregulated at the translational level because the 
open reading frames of biotin operon genes often overlap with those of the upstream 
and downstream consistent with translational coupling (Shapiro, Chakravartty et al. 
2012).  Finally the operon-encoded BioH proteins may have been altered to modulate 
their activities and increase their specificity relative to the freestanding BioH proteins, 
those encoded outside operons.  To test this hypothesis we determined the relative 
expression levels, catalytic activities and specificities of two BioH proteins, those 
encoded by the freestanding E. coli bioH and the operon-encoded bioH of 
Pseudomonad aeruginosa PAO1. 
Materials and Methods 
 
Chemicals, Bacterial Strains and Growth Media.  The antibiotics and most chemicals 
used in this study were purchased from Sigma or Thermo Fisher unless noted otherwise. 
Oligonucleotide primers were synthesized by Integrated DNA Technologies and are 
shown in Table 1. PCR amplification was performed using Pfu (Stratagene) or Taq 
(New England Biolabs) polymerases. New England Biolabs supplied restriction 
enzymes and T4 DNA ligase. DNA sequencing was performed by AGCT, Inc. Invitrogen 
provided the Ni++-agarose column. P. aeruginosa PAO1 genomic DNA was extracted 
using a genomic DNA purification kit (Promega). Antibiotics were used at the following 
concentrations: kanamycin sulfate, 30 μg·mL−1; chloramphenicol, 30 μg·mL−1; 
gentamycin sulfate 50 μg·mL−1; tetracycline hydrochloride 60 μg·mL−1. The bacterial 
strains used were derivatives of E. coli K-12 or P. aeruginosa PAO1 (Table 2). The rich 
medium used for strain growth was LB broth. The defined medium was M9  medium 
supplemented with 0.3% (wt/vol) glucose and 0.1% (wt/vol) Casamino acids. 
 
Molecular Cloning  The P. aeruginosa bioH and bioC genes were amplified from P. 
aeruginosa PAO1 genomic DNA using primers BioH-F, BioH-R and BioC-F, BioC-R 
(Table 3-1) and ligated into pET-28b(+) (Novagen) between the NcoI and XhoI sites for 
expression of the protein having a C-terminal hexahistidine tag. Plasmid pXC.039 
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(Table 3-2) encoding the P. aeruginosa C-terminal His-tagged BioH was sequence 
verified and transformed into BL21(DE3) to give strain XC.037. Plasmid pSTL6 
encoding the E. coli BioH with a C-terminal hexahistidine tag  and pSTL42 encoding the 
E. coli BioH and a C-terminal hexahistidine-tagged BioC were from laboratory stocks.  
 
Protein Purification  Strain XC.037 carrying pXC.039 encoding P. aeruginosa BioH 
and strain STL14 carrying pSTL6 encoding E. coli BioH (Table 3-2) were grown to 
OD600 of 0.8 in LB-kanamycin medium at 37°C followed by induction for 4 h by addition 
of 1 mM IPTG. The cells of a 500 ml culture of each strain were collected. All protein 
purification and manipulations were performed at 4°C or on ice. The cell pellets were 
resuspended in lysis buffer containing 20 mM sodium MOPS (pH 8.0), 500 mM NaCl, 
and 10% glycerol and lysed by multiple passages through a French Press. The soluble 
cell extract was collected and mixed with Ni-NTA resin (Qiagen) for 2 h. The resin was 
then loaded into a column and washed twice with 40 mM lysis buffer containing 30 mM 
imidazole. The column was eluted with 250 mM imidazole and protein fractions were 
collected. Protein purification was monitored by SDS/PAGE. The concentrated protein 
solutions were dialyzed overnight in dialysis buffer containing 25 mM sodium MOPS, 10% 
glycerol, 1 mM tris(2-carboxyethyl)phosphine hydrochloride and 0.2 M NaCl (pH 7.5) 
followed by flash freezing and storage at -80°C.  
 
Structural Modeling and Sequence Alignment  A model of P. aeruginosa PAO1 BioH 
was determined by threading it with the E. coli BioH crystal structure (PDB: 1m33) using 
the automated mode of SWISS-MODEL(Peitsch 1996, Arnold, Bordoli et al. 2006, 
Kiefer, Arnold et al. 2009). The final image was generated using the UCSF Chimera 
package(Pettersen, Goddard et al. 2004). Sequence alignment was conducted using 
ClustalW2, and the final output shown in Figure 2 was created by ESPript 3.0(Robert 
and Gouet 2014). 
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Protein mass spectrometry  BioH reaction mixtures (20 μl) were loaded onto Vivapure 
D Mini H columns (Sartorius Stedim) which were washed twice with loading buffer (25 
mM sodium MES, 10 mM DTT, pH 6.1) containing 250 mM LiCl. Acyl-ACPs were eluted 
with same buffer containing 500 mM LiCl followed by dialysis against 200 mM 
ammonium acetate overnight at 4°C using a 3,500 molecular weight cut-off membrane. 
The samples were dried under a nitrogen stream (Cao and Cronan 2015). Mass 
spectral analyses were performed by the University of Illinois Mass Spectrometry 
Laboratory. The mass spectra were collected under low resolution in positive ion mode 
on an UltrafleXtreme MALDI TOF/TOF mass spectrometer (Bruker Daltonics, Bremen, 
Germany) equipped with a frequency tripled Nd–YAG solid state laser using the 
FlexControl 1.4 software package (Bruker Daltonics). 
 
Enzyme Activity Assays  The E. coli and P. aeruginosa ACP proteins were expressed 
and purified as previously described (Christensen and Cronan 2009). Enzymatic assays 
of the BioH proteins were performed using the protocol established for E. coli BioH with 
modifications (Agarwal, Lin et al. 2012). Each reaction contained 50 mM Tris-HCl (pH 
7.0), 5% glycerol, 50 μM acyl-ACP esters and a series of BioH dilutions (0.3-25 nM). 
The total volume for each reaction was 5 μL. A premix of buffer and pimeloyl-ACP 
methyl ester (or a shorter or longer homologue) was incubated at 37 °C for 1 min 
without BioH. Each reaction was initiated by adding BioH and incubated at 37 °C for 2 
min. The reactions were stopped by adding an equal volume of 10 M urea and placed 
on dry ice. For analysis the reaction mixtures were loaded into 20% PAGE gels 
containing 2.5 M urea and run at 130 V for 2.5 h. Acyl-ACP esters with different chain 
lengths and ester moieties were synthesized as previously described (Agarwal, Lin et al. 
2012). 
 
Construction of the P. aeruginosa bioD ::Gm mutant strain  The P. aeruginosa 
bioD:: Gm mutant strain was constructed by following the procedure described by Lei et 
al (Zhu, Lin et al. 2010). Briefly, to disrupt P. aeruginosa bioD, a suicide plasmid was 
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constructed as follows. The 150 bp regions upstream and downstream of bioD (called 
UpbioD and DownbioD, respectively) were amplified with Pfu DNA polymerase using 
strain PAO1 genomic DNA as the template and either oXC48 and oXC51 (for UpbioD) 
or oXC49 and oXC50(for DownbioD) as the primers (Table 3-1). Primers oXC50 and 
oXC51 both added BamHI sites in the end. A 750-bp gentamicin resistance cassette 
was cut by restriction enzyme BamHI from plasmid p34s-Gm (Dennis and Zylstra 1998). 
The PCR products of UpbioD, DownbioD and DNA fragment of Gm were purified, and 
overlapping PCR was carried out using primers oXC48 and oXC49, which added EcoRI 
and HindIII restriction sites. The 1,000 bp ∆PabioD::Gm PCR fragment was cloned into 
the same sites of pK19mobsacB to yield pXC.040. pXC.040 was then transformed into 
the E. coli donor/helper strain S17.1 and transferred by conjugation into P. aeruinosa 
PAO1. Cells were spread on LB agar plates containing chloramphenicol (to select 
against the donor strain) plus gentamicin to select for integration of the nonreplicating 
plasmid into the chromosome of the recipient. Colonies resistant to chloramphenicol 
and gentamicin were then counter-selected on 10% sucrose LB agar plates. Colonies 
were screened by colony PCR using primers oXC48 and oXC49 (Table 3-1). 
 
Modification of genomic bioH genes with a hexahistidine (His6) coding sequence 
Insertion of a sequence encoding C-terminal His6 tag into the E. coli genomic bioH was 
performed as by a standard method (Datsenko and Wanner 2000). Strain STL111 
(MG1655 ∆bioD::kan) was used as the target strain. Briefly, the 35 bp N-terminal and C-
terminal regions of bioH were amplified with Pfu DNA polymerase using pKD3 as the 
template and P1-P2 as the primers (Table 3-1). The sequence encoding a His6 tag and 
a stop codon were included on the P1 priming site. The resulting 1.1-kbp PCR product 
was purified, treated with DpnI and transformed into strain XC.047 carrying the Red 
recombinase plasmid pKD46 (Table 3-2). Colonies that grew on LB chloramphenicol 
plates indicated that the double homologous recombination was successful and the 
sequence encoding the His6 tag had been inserted onto the end of the bioH gene. 
Finally, the Cm marker was excised by the Flp recombinase encoded by pCP20 (Table 
59 
 
3-2) to yield XC.052. The genomic His6 tagged bioH was then PCR amplified with 
oXC53 and oXC54 and sequence verified. 
 
Insertion of a sequence encoding a C-terminal His6 tag into the P. aeruginosa genomic 
bioH was performed by the counter-selection method described above. Strain XC.059 
(PAO1 bioD::Gm) was used as the target strain. In brief, the 2.6 kb bioH::His6-Tet PCR 
fragment was inserted into the same sites of pK19mobsacB to yield pXC.041. pXC.041 
was then transformed into the E. coli donor/helper strain S17.1 and transferred by 
conjugation into XC.059 (PAO1 bioD::Gm). Cells were spread on LB agar plates 
containing chloramphenicol (to select against the donor strain) plus tetracycline (60 
μg/ml) to select for integration of the nonreplicating plasmid into the chromosome of the 
recipient. Colonies resistant to both chloramphenicol and tetracycline were then 
counter-selected on 10% sucrose LB plates. Colonies that grew indicated that the 
double homologous recombination was successful and the sequence encoding the His6 
tag had been inserted onto the end of the P. aeruginosa bioH gene.  The insertion was 
verified by sequencing the PCR fragment obtained using primers oXC126 and oXC131 
(Table 3-1). The verified strain was named XC.109. 
 
RNA Isolation and Real-time Quantitative RT-PCR  Mid-log phase cultures of E. coli 
∆bioD (STL111)and P. aeruginosabioD:: Gm (XC.059) grown in M9 medium 
supplemented with low (1.6 nM) and high (40 μM) biotin concentration were collected 
for total bacterial RNA preparations. The RNeasy bacterial RNA isolation kit (Qiagen, 
Hilden, Germany) was utilized. The quality of the acquired RNA samples was visualized 
using agarose gel electrophoresis. 
 
Real time RT-PCR reaction system (20 μL) contained 12.5 μL of iQTM SYBR Green 
Supermix, 1 μL of each primer, 1 μL of the diluted cDNA sample, and 4.5 μL of sterile 
water. All data were collected in triplicate on a Mastercycler eprealplex2 (Eppendorf), 
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using the program of a denaturing cycle at 95°C for 2 min, 40 cycles comprising 95°C 
for 15 sec, 60°C for 15 sec, and 68°C for 20 sec and a final step featuring with gradient 
temperature from 60°C to 90°C for dissociating double stranded DNA products. 
Amplification efficiency for all primer pairs was evaluated using serial ten-fold dilutions 
of pooled cDNA (100, 10, 1, 0.1, 0.01 ng) or plasmids (2500, 250, 25, 2.5, 0.25 fM). 
Plasmids pSTL42 encoding E. coli BioH and BioC, pXC.039 encoding P. aeruginosa 
BioH and pXC.042 encoding P. aeruginosa BioC (Table 3-2) were adjusted to 25 nM 
(equal to about 100 ng/µl) to give standard templates. To preclude inaccurate DNA 
concentrations an equal volume mixture of three plasmids was utilized as the 25 nM 
standard plasmid samples. A primer pair (oXC201, oXC202, Table 3-1) for the pET 
plasmid was designed to determine accurate concentrations of each plasmid based 
upon the 25 nM standard plasmid sample. Real time qRT-PCR was performed for the 
ten-fold dilutions of the standard plasmid samples (10-4 to 10-8), and the linear 
conversion equations between Ct value and template concentration (logarithm) was 
generated. After five serial ten-fold dilutions, the Ct value of each plasmid was 
determined and the concentration of each plasmid was calculated based on the “Ct 
value-concentration” equation generated above. The same method was utilized to 
determine the concentrations of E. coli ∆bioD cDNA samples and P. aeruginosa bioD :: 
Gm cDNA samples using the respective 16s gene primer pairs (oXC116 & oXC117 and 
oXC188 & oXC189, Table 3-1). 
 
Similarly, for generating the “Ct value-concentration” equation for bioC and bioH genes, 
qRT-PCR was performed using a serial dilutions (10-4 to 10-8) of plasmids pSTL42, 
pXC.039 and pXC.042 as the templates and corresponding primers (oXC92 and oXC93 
for P. aeruginosa bioC, oXC184 and oXC185 for P. aeruginosa bioH, oXC124 and 
oXC125 for E. coli bioC, oXC118 and oXC119 for E. coli bioH) to amplify the bioC and 
bioH genes of E. coli and P. aeruginosa, respectively. Finally, the bioC and bioH copy 
numbers of E. coli cDNA and P. aeruginosa cDNA were calculated via the linear 
equation generated above (1mol = 6 x1023 copy numbers).\ 
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Western Blot Analysis  Strains XC.052 and XC.109 were grown to mid-log phase in 
500 ml of M9 minimum medium plus 0.3% (wt/vol) glucose, 0.1% (wt/vol) Casamino 
acids with limited (1.6 nM) or excess (40 μM) biotin. The soluble cell extracts were 
collected and equal amounts of protein were loaded onto a nickel affinity 
chromatography column. The proteins were purified as above and were analyzed by 
SDS-PAGE. Equal volumes of soluble proteins were loaded and separated on a 12% 
SDS-polyacrylamide gel and transferred by electrophoresis to Immobilon-P membranes 
(Millipore) for 15 min at 15 V. The membranes were preblocked with TBS buffer (100 
mM Tris base and 0.9% NaCl, pH 7.5) containing 0.1% Tween 20 and 5% nonfat milk 
powder. The membranes were probed for 1 h with an anti-His6 protein primary antibody 
(ThermoFisher Scientific) diluted 1:2,000 in the above buffer. Following incubation with 
a peroxidase labeled anti-mouse secondary antibody (diluted 1:5000; GE Healthcare 
Life Sciences), the labeled proteins (His6-tagged BioH) were detected using Quantity 
One software. 
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Results 
 
Both the freestanding and operon-encoded BioH proteins have similarly high 
enzymatic activities.  The operon-encoded BioH of P. aeruginosa has 29% sequence 
identity to the freestanding E. coli BioH over the length of the former (shorter) protein 
(Fig. 3-2A). Expression of the P. aeruginosa in an E. coli ∆bioH strain resulted in robust 
growth in biotin-free medium as expected from prior studies with various 
nonorthologous esterases (Flores, Lin et al. 2012, Shapiro, Chakravartty et al. 2012, 
Feng, Napier et al. 2014, Bi, Zhu et al. 2016) (data not shown). Alignments of the two 
BioH proteins argues that the two enzymes share the same esterase catalytic triad (Ser-
His-Asp) (Fig. 3-2A). Indeed, modeling the operon-encoded BioH structures on the 
known structure of the E. coli BioH argues that the structures are almost identical (Fig. 
3-2C).  Note that despite its low sequence identity with E. coli BioH the P. aeruginosa 
protein is clearly a BioH and not one of the other pimeloyl-ACP methyl ester esterases 
because those nonorthologous proteins cannot be aligned with E. coli BioH even with 
very permissive alignment parameters (Shapiro, Chakravartty et al. 2012, Feng, Napier 
et al. 2014, Bi, Zhu et al. 2016). 
 
The kinetics of E. coli BioH with p-nitrophenyl esters of various acyl chain lengths were 
determined previously (Sanishvili, Yakunin et al. 2003). However, p-nitrophenyl esters 
are not physiological BioH substrates and are more easily hydrolyzed than pimeloyl-
ACP methyl ester. Therefore, we compared the carboxylesterase activity of the two 
BioH proteins using the physiological substrate, pimeloyl-ACP methyl ester. N-terminal 
hexahistidine tagged versions of E. coli BioH and P. aeruginosa BioH were readily 
expressed and purified to homogeneity by nickel-chelating affinity chromatography 
followed by size exclusion chromatography (Fig. 3-2B). To test BioH enzymatic activity 
pimeloyl-ACP methyl ester was synthesized from E. coli ACP (Materials and Methods). 
The pimeloyl-ACP product can be distinguished from the pimeloyl-ACP methyl ester 
substrate by its slower migration in a conformationally sensitive urea-PAGE gel system 
(Fig. 3-3A) (Christensen and Cronan 2009, Lin, Hanson et al. 2010, Shapiro, 
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Chakravartty et al. 2012, Feng, Napier et al. 2014, Bi, Zhu et al. 2016). The reactions 
were performed with serial dilutions of BioH at a constant substrate concentration (50 
μM pimeloyl-ACP methyl ester), production of pimeloyl-ACP by both BioH proteins could 
be observed with as little as 1.25 nM enzyme (Fig. 3-3B). For the freestanding E. coli 
BioH, the reaction approached completion with 2.5 nM enzyme whereas the reaction 
completion was seen at 5 nM for operon-encoded P. aeruginosa BioH (Fig. 3-3B). The 
reaction mixtures were analyzed by mass spectrometry which showed conversion of 
pimeloyl-ACP methyl ester to pimeloyl-ACP by loss of a methyl group (Fig. 3-3C, only 
the reaction catalyzed by operon-encoded BioH is shown). Pimeloyl-ACP methyl ester 
synthesized from P. aeruginosa ACP was also utilized as substrate and gave essentially 
identical results (data not shown) indicating that the ACP source was immaterial. This 
was expected since P. aeruginosa ACP is 90% identical to E. coli ACP and the α2-
helices of the two proteins have identical sequences. Since α2-helix provides most of 
the residues that interact with BioH (Agarwal, Lin et al. 2012), E. coli ACP is an 
excellent surrogate for P. aeruginosa ACP. Note that quantitation of BioH activity is 
problematical and accurate Michaelis-Menton data could not be obtained.  This was 
because detection of the cleavage reaction requires that an appreciable fraction of the 
substrate be converted to product (the substrate concentration can go to zero) and 
densitometry is imprecise because separation quality and background vary from gel to 
gel. Moreover, substrate concentrations cannot be varied over a wide range because of 
lack of sensitivity at low concentrations and poor resolution of substrate and product at 
high concentrations. For these reasons, we have chosen to assay BioH activity by 
varying the enzyme concentration. Indeed, relative to the freestanding E. coli BioH only 
twice the enzyme concentration was required for the operon-encoded P. aeruginosa 
BioH to complete pimeloyl-ACP methyl ester hydrolysis.  Hence, both the freestanding 
BioH and operon-encoded BioH proteins possess high enzymatic activity. 
 
The operon-encoded BioH has a broad substrate specificity similar to that of the 
freestanding BioH.  E. coli BioH has a small lid domain and a large core domain where 
the active site resides (Sanishvili, Yakunin et al. 2003, Agarwal, Lin et al. 2012),. The 
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function of the lid domain was unclear until Agarwal and coworkers showed that the lid 
domain provides most of the residues that interact with the α2-helix of the substrate 
ACP moiety (Agarwal, Lin et al. 2012) consistent with molecular dynamics simulations 
of BioH specificity (Xue, Cui et al. 2016). Previous experiments have shown that the 
freestanding E. coli BioH hydrolyzed the ester bonds of acyl-ACP esters of different 
chain characteristics in vitro (Christensen and Cronan 2010). To test if this is the case 
for the operon-encoded BioH, we synthesized various ω-carboxyl-acyl-ACP esters from 
E. coli ACP and assayed the in vitro abilities of the two BioH proteins to cleave the ester 
moieties of these substrates. Both BioH enzymes readily hydrolyzed the methyl esters 
of adipyl-, suberyl- and azelayl-ACPs (the C6, C8 and C9 acyl chains) but failed to 
cleave succinyl-ACP methyl ester (Fig. 3-4A). Glutaryl (C5) methyl ester was cleaved 
less efficiently than pimeloyl-ACP methyl ester by both BioH proteins (Fig. 3-4A). In 
addition, both BioH proteins cleaved the ethyl, propyl and butyl esters of pimeloyl-ACP 
(Fig. 3-4B). These results indicate that operon-encoded BioH and freestanding BioH 
have similarly broad substrate specificities. 
 
The operon-encoded bioH is transcribed at higher levels than the freestanding 
bioH.  Biotin operon transcription is regulated in response to biotin availability by BirA 
(Barker and Campbell 1981). When the intracellular biotin concentration is high and the 
biotin acceptor proteins have been modified, biotin will be activated by BirA to form the 
BirA-biotinyl-5’-AMP complex, the ligation reaction intermediate (Beckett 2007). Bound 
biotinyl-5’-AMP greatly increases the ability of BirA monomers to form dimers, the 
species required for binding of the operator located between the divergent bioA and 
bioBCDF genes which results in repression of both transcripts (Fig. 3-5).  When the 
intracellular biotin concentration is low and unmodified biotin acceptor protein 
concentration is present, BirA will transfer biotin from biotinyl-5’-AMP to the specific 
lysine residues of its cognate proteins.  The consumption of biotinyl-5’-AMP results in 
loss of BirA dimers and derepression of biotin operon transcription (Fig. 3-5) (Barker 
and Campbell 1980, Cronan 1988, Beckett 2007).  
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BioC and BioH work in tandem to synthesize the pimeloyl-ACP precursor that provides 
the biotin valeric acid chain and upon reaction with alanine begins biotin ring synthesis 
(Lin, Hanson et al. 2010, Lin and Cronan 2012). In order to compare bioH and bioC 
transcription levels in E. coli and P. aeruginosa, two biotin auxotrophic strains, E. coli 
∆bioD (STL111) and P. aeruginosa bioD::Gm (XC.059)were used (Fig. 3-6A). The P. 
aeruginosa bioD::Gm we constructed grew on defined medium plates only when 
supplemented with biotin indicating successfully disruption of bioD. (Fig. 3-6B).  
 
Real-time qRT-PCT was performed to examine the transcription levels of bioH versus 
bioC in the E. coli ∆bioD and P. aeruginosia bioD::Gm strains. The cultures were grown 
in defined medium containing 1.6 nM biotin, a limiting concentration which permits 
growth of biotin auxotrophs and derepression of biotin operon transcription or in 40 μM 
biotin, a concentration that represses expression. The cells of mid-log phase cultures of 
E. coli ∆bioD and P. aeruginosa bioD::Gm strains grown in defined medium in the two 
biotin concentrations were collected and used to obtain total RNA preparations. The 
amplification efficiency for each pair of primers was evaluated (Materials and Methods). 
A linear equation of “Ct-value vs gene concentration” for bioC and bioH was generated 
with the corresponding primer pairs. The real-time qPCR-based analyses of 
transcriptional profile showed that in the E. coli ∆bioD strain, bioC gene was transcribed 
about 3-fold more than the bioH gene under derepression conditions (1.6 nM biotin), 
whereas the transcription levels of bioC and bioH expression were similar under 
repressed conditions (40 μM biotin) (Fig. 3-7). The relative expression levels of bioH 
and bioC in the P. aeruginosa bioD::Gm strain remained the same under both biotin 
concentrations (Fig. 3-7) consistent with cotranscription of the genes. The real-time 
qRT-PCR data indicates that the freestanding bioH gene is transcribed at lower levels 
than the operon-encoded bioH gene. 
 
 Freestanding BioH is produced at lower levels than operon-encoded BioH.  In 
order to detect the levels of the freestanding and operon-encoded BioH proteins, we 
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modified the chromosomal bioH genes of both bacteria with a sequence encoding a 
His6 C-terminal extension to allow antibody detection. Cells were collected at mid-log 
phase from cultures grown in defined medium that contained either excess or limited 
biotin.  Note that biotin biosynthetic enzymes are expressed at very low levels because 
the demand for biotin is miniscule. Growth of E. coli requires only a few hundred biotin 
molecules per cell(Cronan 2001).  Consistent with the low demand for biotin, ribosome 
profiling indicates that an E. coli cultures grown on defined medium contain only 158 
molecules of BioH per cell (Li, Burkhardt et al. 2014).  Indeed, we were unable to detect 
E. coli and P. aeruginosa His6-tagged BioH proteins in unfractionated cell extracts by 
western blot analysis. For this reason we enriched and concentrated the BioH proteins 
from 500 ml cultures by binding to a nickel chelate column prior to western blot analysis 
of the eluates. Equal amounts of protein from each culture were loaded on the columns 
and then equal volumes of the eluted enriched preparations were loaded on the 
denaturing electrophoresis gels together with purified E. coli and P. aeruginosa His6-
tagged BioH proteins as positive controls.Western blot analysis of cell extracts with an 
anti-hexahistidine antibody showed different levels of BioH production in E. coli ∆bioD 
and P. aeruginosa bioD::Gm strains. Under limited biotin conditions, a BioH protein 
band was readily observed in the P. aeruginosa bioD::Gm His6-bioH strain whereas in 
cells grown with excess biotin, no BioH band was detectable indicating repression by 
biotin (Fig. 3-8). In contrast, the E. coli ∆bioD His6-bioH strain the BioH protein band 
was very faint even in biotin limited cells consistent with its reported lack of regulation 
by biotin availability (Barker and Campbell 1980, N Koga, Kishimoto et al. 1996)(Fig. 3-
8). Given these data and the real-time qRT-PCR data we conclude that the freestanding 
bioH mRNA was translated markedly less efficiently than the operon-encoded bioH 
mRNA.  The efficient translation of the P. aeruginosa  mRNA might result from 
translational coupling with the upstream bioF gene. 
 
Bioinformatic analysis of freestanding BioH and operon-encoded BioH proteins.  
A phylogenetic tree was constructed using Clustal Omega followed by analysis 
according to Kimura (Kimura 1968, Kimura 1983). The phylogeny of freestanding BioH 
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from E. coli and operon-encoded BioH from P. aeruginosa were determined together 
with other BioH homologs (Fig. 3-9). This analysis revealed that the freestanding BioH 
proteins and operon-encoded BioH proteins form distinct clades.  
Discussion 
BioH is a member of the α/β-hydrolase fold superfamily which is readily evolvable to 
give enzymes of diverse function (Jochens, Hesseler et al. 2011). The BioH function 
seems something of a “wild card” among biotin synthetic enzymes since various 
nonorthologous substitutes of bioH have been observed in numerous bacterial genomes. 
In place of bioH, genes called bioG, bioK, bioJ and bioV and the proteins they encode 
have been shown to have bioH function in vivo and in vitro.  (Rodionov, Mironov et al. 
2002, Shapiro, Chakravartty et al. 2012, Feng, Napier et al. 2014, Bi, Zhu et al. 2016). 
BioH functions in tandem with BioC (Lin, Hanson et al. 2010, Lin and Cronan 2012). 
The bioC gene is conserved among highly divergent groups of bacteria, even in those in 
which bioH has been displaced by genes encoding proteins having very low sequence 
identity with BioH. E. coli BioH, the canonical freestanding enzyme, has a broad 
substrate specificity and modestly higher enzymatic activity than the P. aeruginosa 
operon-encoded BioH. However our hypothesis to explain the ambiguity between 
freestanding bioH and operon-encoded bioH genes has now been resolved by the 
demonstration that the two BioH proteins, have similar enzymatic activities and similar 
broad substrate specificities. Hence, the expectation that expression of the operon-
encoded bioH mRNA would have become “domesticated” and would be transcribed and 
translated at lower levels than the freestanding bioH mRNA was not fulfilled.  Indeed, 
the operon-encoded enzyme was expressed at higher levels. 
 
Unexpectedly both the freestanding BioH and operon-encoded BioH proteins have 
much higher enzymatic activity than the biotin synthesis enzymes involved in 
assembling the heterocyclic rings. In this regard it is interesting that evolution of a P. 
aeruginosa carboxylesterase (PA3859) of unknown function to gain BioH activity 
required  only simple amino acid substitutions. and only when high in vitro activity 
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against pimeloyl-ACP methyl ester had been attained did the mutant PA3859 proteins 
support growth at rates similar to that given by E. coli BioH (Flores, Lin et al. 2012). A 
recent study of the enzyme encoded by Haemophilus influenzae bioG, the gene often 
found in place of bioH immediately upstream of bioC, encodes an enzyme of activity 
comparable to that of E. coli BioH (Shi, Cao et al. 2016). Therefore, it is tempting to 
conclude that BioH and its related isofunctional enzymes all have high enzymatic 
activity and might have been captured for evolutionary contingency by natural selection 
(Nei 2005). This, together with our results, suggests that both freestanding BioH and 
operon-encoded BioH function can be provided by homologous proteins that have 
diverged extensively while retaining the required enzymatic function. High activity would 
have the advantage of preventing wasteful elongation of pimeloyl-ACP methyl ester to 
longer species.  However, extremely high esterase activity could be counterproductive 
because glutaryl-ACP methyl ester might be cleaved which would abort pimelate 
synthesis.   
 
The diversity of the esterases that cleave pimeloyl-ACP methyl ester is atypical and 
intriguing.  Generally speaking when a pathway is conserved, all of the enzymes are 
conserved. Our finding that the freestanding BioH proteins form a clade that seems 
distinct from the operon-encoded encoded BioH proteins adds to the intrigue (Fig. 9).  
The freestanding bioH genes seem to be more recent acquisitions than the esterases 
encoded within biotin operons because the coding sequences of the operon-encoded 
bioH genes often overlap with those of the upstream and downstream genes (8 bp each 
for the P. aeruginosa bioH). Developing this sophisticated arrangement necessarily 
involves making a coding region from noncoding DNA, a process that seems likely to 
require numerous cycles of purifying selection and optimization (Rogozin, Spiridonov et 
al. 2002).  
 
Many genes encoding putative α/β-hydrolases are present in bacterial genomes and 
thus freestanding pimeloyl-ACP methyl ester hydrolases cannot be recognized unless 
69 
 
the proteins align very well with a protein of known activity or lies in a specific genome 
neighborhood. Indeed, both E. coli bioH and F. novicida bioJ were discovered by 
serendipity in searches for mutants in pathways unrelated to biotin synthesis whereas 
bioV was isolated by complementation screening of H. pylori genome fragments. 
Searches for transcriptional regulatory sequences upstream of coding sequences is 
also problematical since expression of the known freestanding genes (E. coli bioH and 
F. novicida bioJ) are not subject to the same regulation as the cognate biotin operons 
(the H. pylori biotin synthetic genes are scattered about the genome).  Hence numerous 
unrecognized freestanding pimeloyl-ACP methyl ester hydrolases may be present in 
bacterial genomes.  However, Akatsuka and coworkers reported a genome 
neighborhood (Akatsuka, Kawai et al. 2013) that seems to provide a means to find 
some freestanding bioH genes. They observed that an ORF upstream of the Serratia 
bioH encoded a protein with homology to Haemophilus influenzae ComFC and that this 
genome neighborhood was conserved in several other bacterial species (Akatsuka, 
Kawai et al. 2013).  Moreover in a few bacteria other biotin synthetic genes are found 
neighboring bioH and comFC. These workers clearly demonstrated that the putative 
Serratia gene encoded a bona fide BioH.  The protein is 70% identical to E. coli BioH 
and expression of the gene complemented growth of an E. coli bioH mutant strain. 
Moreover disruption of the gene engendered a biotin requirement (Akatsuka, Kawai et 
al. 2013).   
 
Hence the linkage to comFC seems a reliable indication that the downstream gene 
encodes a BioH homologue rather than another type of α/β-hydrolase.  If so,the 
encoded protein should show high sequence identity with the E. coli and Serratia BioH 
proteins and the biotin operons of candidate bacteria should lack an α/β-hydrolase-
encoding gene. We found that these criteria were fulfilled in several diverse bacterial 
species: Yersinia, Erwinia, Pectobacterium, Enterobacter, Klebsiella, Cronobacter, 
Citrobacter, Klebsiella, Salmonella, Shewanella and Edwardsiella.  All of these 
genomes encoded a protein having greater than 63% identity to the E. coli and Serratia 
BioH proteins (except Shewanella which was 45%) and several approached 80% 
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identity.  In contrast two operon-encoded BioH proteins, those of P. aeruginosa and 
Bacillus cereus, showed much lower identities with the freestanding BioH proteins, 29% 
and 18%, respectively.  Moreover the P. aeruginosa and Bacillus cereus proteins 
showed only 21% identity.  Indeed when the BioH sequences were submitted to Clustal 
Omega alignment and the results analyzed according to Kimura (Kimura 1968, Kimura 
1983), the freestanding and operon-encoded BioH proteins fell cleanly into two clades.  
Moreover, the same clades were found when two other analysis approaches, 
Uncorrected Pairwise Distance and Scoredist (Sonnhammer and Hollich 2005),were 
applied. 
 
The bioinformatics analyses argue that the freestanding BioH proteins have diverged 
less than the operon-encoded proteins from the common ancestor. This may be the 
case but the situation is greatly complicated by the presence of nonorthologous genes 
that encode both freestanding and operon-encoded proteins with pimeloyl-ACP methyl 
ester hydrolase activity (Rodionov, Mironov et al. 2002, Shapiro, Chakravartty et al. 
2012). Another bewildering conundrum is the species specificity of the nonorthologous 
BioJ, BioK and BioV proteins. An especially puzzling case arises in Francisella species 
which have a bioABFCD operon that has the same gene order and spacing as that of E. 
coli. Moreover, the Francisella BirA regulatory protein weakly regulates transcription of 
the E. coli bio operon (Feng, Chin et al. 2015). However, Francisella species lack BioH 
and instead encode BioJ, an appreciably larger freestanding α/β-hydrolase that lacks 
sequence similarity with BioH (Feng, Napier et al. 2014). Given these considerations we 
are unable to assign a straightforward phylogeny for BioH. 
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Tables 
Table 3-1. Oligonucleotides (5’-3’) Used in Chapter 3 
BioH-F BioH Forward ATACTACCATGGATGCGTGACCACTTGAT 
CCTGTTGCCGGGCT 
BioH-R 
 
BioC-F 
BioC-R      
P1 
 
                            
 
P2           
BioH Reverse 
 
BioC Forward 
BioC Reverse 
P1 priming site for E. coli 
genomic bioH-His6 
 
 
P2 priming site for E. coli 
genomic bioH-His6 
 
ACTACTCGAGGGCATCGTCACCCTCGCGA 
AGGAATCTCA 
ATACTACCATGGATGCCTGACGATTCCTCG 
ACTACTCGAGGGAATCCTTGCGCAGCAC 
CGAGTTTTGTCACCTGCTGGTGGCGTTGAA 
GCAGAGGGTGCATCACCATCACCATCACT 
AATGTGTAGGCTGGAGCTGCTTC 
 
GCGAGTCAGTAAAGTTCTGTCTCGCCATTTC 
AAAAGCCACCATATGAATATCCTCCTTA 
oXC48 UpbioD Forward (EcoRI) ACATGAATTCCACAACCTCAACCCCGGGC 
oXC49 DownbioD Reverse (HindIII) ATACAAGCTTCGCGTTGAGGCCACTGACGA 
oXC50 DownbioD Forward (BamHI) TTCACCCTGGTGGATCCGGAGGGCGC 
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Table 3-1 (cont.) 
oXC51 
oXC53 
oXC54     
oXC92 
oXC93 
oXC116 
oXC117 
oXC118 
oXC119 
oXC124  
oXC125  
UpbioD Reverse (BamHI) 
E. coli bioH Reverse 
E. coli bioH Forward 
PAO1 bioC Forward (q-RT) 
PAO1 bioC Reverse (q-RT) 
E. coli 16S Forward (q-RT) 
E. coli 16S Reverse (q-RT) 
E. coli bioH Forward (q-RT) 
E. coli bioH Reverse (q-RT)  
E. coli bioC Forward (q-RT) 
E. coli bioC Reverse (q-RT)  
GCGCCCTCCGGATCCACCAGGGTGAA 
GCGAGTCAGTAAAGTTCTGTCTCGCCATTTC 
AACTCAGTGATGATTTTCAGCGTAC 
TTCGTCCACGTCAATCGCT 
GCCTTGAGTTCGTGGGTCA 
TACCGCATAACGTCGCAAGA 
TTCCAGTGTGGCTGGTCATC 
ATTGCGTTAACCCATCCCGA 
GTTTGTAACGCCAGGAACCG 
CGACGTTCGATCTTGCATGG 
GATAATGCACGCCGTTCAGC 
oXC126 PAO1 bioH::His6-Tet 
Forward 
ATATAGAATTCAACTCGACGATA 
ACCTGCCGCGCGATA 
oXC131 
oXC184 
oXC185 
oXC188 
oXC189 
oXC201 
PAO1 bioH::His6-Tet Reverse 
PAO1  bioH Forward (q-RT) 
PAO1  bioH Reverse (q-RT) 
PAO1  16S Forward (q-RT) 
PAO1 16S Reverse (q-RT) 
pET28b Kan Forward (q-RT) 
ATGCAGGAGCCGGTCCTCGT 
TGCGTGACCACTTGATCCTG 
CGGCAGGTTATCGTCGAGTT 
CAAGGCGACGATCCGTAACT 
ATCAGGCTTTCGCCCATTGT 
CGGTTTGGTTGATGCGAGTG 
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Table 3-1 
oXC202      
(cont.) 
pET28b Kan Reverse (q-RT) 
 
GTGACGACTGAATCCGGTGA 
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Table 3-2. Bacterial Strains and Plasmids Used in Chapter 3 
Strains                  
E. coli 
Relevant  Genotype or Description                                                       Ref. or Derivation 
 
MG1655 E. coli K-12 wild type Lab stock 
BL21(DE3) 
S17.1           
E. coli B ompT hsdSB gal dcm (DE3) 
F- thi pro hsdR [RP4-2 Tc::Mu Km:: Tn] 
Lab stock 
Lab stock 
STL14 
STL111 
XC.037 
XC.047  
XC.052  
P.aeruginosa 
(PAO1)               
BL21 (DE3)/pSTL6 
MG1655 ∆bioD::kanr 
BL21 (DE3)/pXC.039 
STL111/pKD46 
MG1655 ∆bioD bioH::His6-FRT 
 
(Lin, Hanson et al. 2010) 
Lab stock 
This study 
This study 
This study 
 
Lab stock 
XC.059 
XC.109  
PAO1 bioD::Gm 
PAO1 bioD::Gm bioH::His6-Tet 
This study 
This study 
   
Plasmids   
pET28b 
pKD3 
pKD46 
T7 promoter expression vector, KanR 
template plasmid for FRT-flanked cat 
cassette 
encodes recombineering phage lambda Red  
Novagen 
(Datsenko and Wanner 
2000) 
(Datsenko and Wanner 2000) 
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 Table 3-2 
pCP20                     
(cont.) 
encodes the yeast Flp recombinase gene 
 
(Cherepanov and 
Wackernagel 1995) 
pSTL6 
 
pSTL42               
pET28b encoding C-terminal His-tagged E. 
coli BioH 
pET28b encoding E. coli BioH plus His6-
tagged E. coli BioC  
(Lin, Hanson et al. 2010) 
 
Lab stock 
pXC.039 
 
pXC.042 
pET28b encoding C-terminal His-tagged P. 
aeruginosa BioH 
PET28b encoding C-terminal His-tagged P. 
aeruginosa BioC 
This study 
 
This study 
 
pXC.040                
 
A 1,000 bp PCR fragment containing the P. 
aeruginosa bioD::Gmr cassette in 
pK19mobsacB, Gmr, Kanr 
 
This study 
pXC.041 
 
 
 
 
A 2.6 kbp PCR fragment containing the P. 
aeruginosa bioH::His6-Tet cassette in 
pk19mobsacB, Tetr, Kanr 
 
 
This study 
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Figures 
 
 
 
Figure 3-1. The E. coli biotin biosynthesis pathway and genetic organizations of the E. 
coli and P. aeruginosa biotin synthesis genes. (A), Scheme of the biotin synthesis 
pathway. (B) The biotin synthesis gene organizations of E. coli and P. aeruginosa. Note 
that in E. coli, the five bioABFCD genes are located within the biotin synthesis (bio) 
operon at min 17 of the chromosome map whereas the bioH gene is at min 74 of the 
genetic map and thus is well removed from the bio operon.  
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Figure 3-2. Sequence alignments, purification and modeling of BioH proteins. (A), 
sequence alignment of the BioH proteins of E. coli and P. aeruginosa PAO1. Conserved 
residues are shown as white letters on a red background, and similar residues are 
shown as red letters in blue boxes. The E. coli BioH secondary structure (Protein Data 
Bank ID 1m33) is shown at the top of the panel. The catalytic triad residues are denoted 
by black arrow heads. (B) Purification of P. aeruginosa BioH (lane 1) and E. coli BioH 
(lane 2). The molecular masses of prestained broad-range protein standards (Bio-Rad) 
are indicated. The proteins were purified as described under “Experimental Procedures” 
and analyzed by SDS-PAGE on a 15% polyacrylamide gel. (C) Structural model of P. 
aeruginosa BioH (cyan) obtained by threading on the structure of E. coli BioH (grey) 
using the SwissModel website and PDB 1m33. Helices 2 and 3 of the lid domain of E. 
coli BioH are colored magenta. The side chains of the catalytic triad residues are 
coloured yellow. 
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Figure 3-3. Enzymatic activities of E. coli and P. aeruginosa BioH proteins against 
pimeloyl-ACP methyl ester. (A), Schematic diagram of the BioH catalyzed reaction and 
its analysis. (B), Enzymatic assays for hydrolysis of pimeloyl-ACP methyl ester to 
pimeloyl-ACP by P. aeruginosa and E. coli BioH proteins. The triangles represent BioH 
levels in a dilution series. (C), Mass spectrometry analysis of the BioH reaction. Only 
the P. aeruginosa BioH reactions are shown. Three ACP species were detected when 
ACP was over-expressed in E. coli due to titration of the deformylase and methionine 
aminopeptidase that process the formylated N-terminal residue from nascent proteins. 
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Figure 3-4.  BioH-catalyzed hydrolysis of the ester bonds of various ω-carboxyl acyl-
ACP esters. The reactions contained 50 mM Tris-HCl (pH 7.0), 5 % glycerol, 5 μg/ml 
BioH and 2 mM pimeloyl-ACP esters and were incubated at 37 °C for 30 min.  BioH 
cleavage of the methyl ester moieties of acyl-ACP methyl esters having acyl chain 
lengths of 4 to 9 carbon atoms. (B) BioH cleavage of the ethyl-, butyl- and propyl- esters 
of pimeloyl-ACP. 
  
80 
 
 
 
Figure 3-5. Regulation of the E. coli biotin operon transcription by the BirA ligase/biotin 
repressor. General model of BirA bio operon regulation in E. coli. Green ovals, BirA; 
tailed blue ovals denote the biotin acceptor protein, AccB; black dots denote biotin; 
black dots with red pentagons denote biotinoyl-5’-adenylate. The left panel shows 
derepression of bio operon transcription engendered by biotin limitation whereas the 
right panel shows the transcriptionally repressed state under excess biotin. 
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Figure 3-6. Construction and characterization of the P. aeruginosa ∆bioD strain. (A) 
Recombination events required to generate the mutant strain by sacB counterselection 
gene replacement. (B) Characterization of the mutation by biotin complementation. 
Strain XC.059 were streaked on M9 defined medium plate with (left, 40 nM) or lacking 
(right) biotin. Abbreviations: kan, kanamycin-resistant gene; GmR, Gm resistant marker; 
ori, pMB1 origin of replication; oriT, origin of transfer; sacB, levansucrase-encoding 
gene. 
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Figure 3-7. Transcriptional profiles of bioH and bioC in E. coli ∆bioD and in P. 
aeruginosa bioD::Gm strains. Cultures were grown to mid-log phase in defined medium 
supplemented with excess biotin (40 μM) or limited biotin (1.6 nM), respectively. 
Absolute transcript values for each gene were obtained individually. Error bars indicate 
standard deviation from three independent experiments. 
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Figure 3-8. Western blot analyses of freestanding and operon-encoded BioH production. 
Equal volumes of the freestanding and operon-encoded protein eluates were loaded 
into each lane of an SDS-polyacrylamide gel. After electrophoresis the proteins were 
transferred to Immobilon-P and the membranes were subjected to immunoblotting with 
anti-His6 tag antibody. Lane 1, the P. aeruginosa bioD::Gm strain expressing 
chromosomal His6-tagged BioH under limited biotin conditions (1.6 nM); Lane 2, the P. 
aeruginosa bioD::Gm strain expressing chromosomal His6-tagged operon-encoded 
BioH under excess biotin conditions (40 μM); Lane 3, negative control, P. aeruginosa 
bioD::Gm strain expressing operon-encoded native BioH lacking a His6 tag under 
limited biotin conditions (1.6 nM);  Lane 4, positive control, purified P. aeruginosa BioH 
protein with a C-terminal His6-tag; L, ladder; Lane 5, positive control, purified E. coli 
BioH protein with a C-terminal His6-tag; Lane 6, negative control, the E. coli ∆bioD strain 
expressing the native freestanding chromosomal bioH lacking a His6 tag under limited 
biotin conditions (1.6 nM);  Lane 7, the E. coli ∆bioD strain expressing a chromosomal 
His6-tagged bioH under excess biotin (40 μM) conditions and Lane 8, the E. coli ∆bioD 
expressing chromosomal His6-tagged freestanding BioH under limited biotin conditions 
(1.6 nM).
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Figure 3-9. Phylogenetic tree of bacterial BioH proteins. The three BioH proteins with 
demonstrated pimeloyl-ACP methyl ester cleavage activity are given in large bold type. 
The PA3859 protein is included as the outlier since it is a P. aeruginosa α/β-hydrolase 
known to lack pimeloyl-ACP methyl ester cleavage activity (Flores, Lin et al. 2012). The 
blue dotted box with the exception of PA3859 denotes the operon-encoded BioH 
proteins. The other BioH proteins (those outside the box) are defined as freestanding. 
The six bacterial species at the top left have very similar genomes with bioH 
immediately adjacent to the divergently transcribed gntX gene. The other freestanding 
bioH genes were identified using the adjacent divergently transcribed comFC gene. The 
additional criteria used in identification of all freestanding genes are described in the 
text. The numbers denote genetic distances which are estimates of the degree of 
divergence between two sequences and indicates the number of mutations (amino acid 
residue changes or insertion-deletions) that have occurred since the two sequences 
shared a common ancestor. The tree was calculated using Clustal Omega 
(http://clustal.org/omega/) and the Kimura metric (Kimura 1968, Kimura 1983). B. cereus 
denotes Bacillus cereus and closely related species because other bacilli (e.g., Bacillus 
subtilis) make biotin using a pathway that does not utilize BioH and BioC (Lin and 
Cronan 2011).   
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CHAPTER 4 
A PUZZLE: EVIDENCE FOR DEVELOPMENT AND 
RETENTION OF A PRIMORDIAL “MOONLIGHTING” 
PATHWAY OF PROTEIN MODIFICATION IN THE ABSENCE 
OF SELECTION 
Introduction  
The straightforward two-enzyme LipB plus LipA E. coli lipoate synthesis pathway is 
found in many, but not all, bacterial species. A more complex pathway is found in 
Bacillus subtilis (Martin, Lombardia et al. 2009, Christensen and Cronan 2010, 
Christensen, Martin et al. 2011, Martin, Christensen et al. 2011). The impetus to study 
this bacterium was the lack of a gene encoding a LipB homologue (Christensen and 
Cronan 2010), although a validated LipA homologue was present (Martin, Lombardia et 
al. 2009). Moreover, the B. subtilis genome encoded what appeared to be three lipoate 
ligase homologues, the paradigm of which, E. coli LplA, scavenges lipoate from the 
environment (Martin, Christensen et al. 2011). Screening of a plasmid library of B. 
subtilis genome fragments for complementation of an E. coli strain lacking LipB gave 
one of the putative lipoate ligase genes. However the gene encoded an octanoyl 
transferase called LipM that had no ligase activity and virtually no sequence 
resemblance to E. coli LipB (Christensen and Cronan 2010).  Another putative lipoate 
ligase gene (LplJ) encoded a true lipoate ligase whereas the third putative lipoate ligase 
gene (lipL) remained an enigma, although it was essential for lipoate synthesis (Martin, 
Christensen et al. 2011). The enzymological characterization of LipM presented a 
quandary in that the purified enzyme was unable to transfer octanoate from octanoyl-
ACP to its cognate pyruvate dehydrogenase (PDH) LDs, although the proteins were 
good substrates for the E. coli LipB octanoyl transferase (Christensen, Martin et al. 
2011). A concern was the possibility that LipM recognition of the B. subtilis PDH 
domains required assembly of the E2 subunit into the very large PDH complexes that 
contain many copies of E2, plus the E1 and E3 subunits.  To avoid the possibility of a 
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complex being the substrate, GcvH, a protein of only 127 residues (and thus only 
slightly larger than the OADH LDs of  ~80 residues), was tested as a LipM substrate. In 
contrast to the cognate PDH LDs, GcvH turned out to be an excellent LipM substrate 
(Christensen, Martin et al. 2011) which raised the possibility that GcvH might somehow 
act as an intermediate between LipM and the OADH LDs. Indeed when LipL, the third 
putative B. subtilis lipoate ligase was purified, the protein had no ligase activity but was 
found to transfer an octanoyl moiety from its amide linkage on GcvH to the PDH LD 
using an acyl-enzyme (acyl-cysteine) intermediate (Christensen, Martin et al. 2011). 
These biochemical experiments argued that GcvH was an obligate intermediate in 
lipoylation of the B. subtilis OADH proteins and therefore B. subtilis ∆gcvH strains 
should be unable to make lipoate and be auxotrophic for lipoate. This was the case: the 
small GcvH protein is required for both lipoylation of the B. subtilis OADH subunits 
(PDH for aerobic metabolism and BCDH for fatty acid synthesis) and for glycine 
cleavage (Christensen, Martin et al. 2011). Hence, a small protein of single carbon 
metabolism has a second “moonlighting” (Copley 2012, Copley 2014, Siddiq, Hochberg 
et al. 2017) function that for simplicity we will refer to as the lipoyl-relay pathway. 
Therefore, although it is a protein of only 127 residues, the Bacillus subtilis glycine 
cleavage H protein (GcvH) has three separate functions in central metabolism. Note 
that phenotypic analyses of the yeast, Saccharomyces cerevisiae, argue that it follows 
the same pathway as B. subtilis although little enzymology has been done (Schonauer, 
Kastaniotis et al. 2009).  
 
Brocklehurst and Perham (Brocklehurst and Perham 1993) first deduced that despite 
low sequence identities (15-20%) the OADH LD structures could be used to accurately 
predict the pea GcvH structure. Although a similar low sequence identity is seen 
between the E. coli OADH LDs and its GcvH, the LipB octanoyl transferase efficiently 
modifies both proteins (Reed and Cronan 1993, Morris, Reed et al. 1995). This is not 
the case with the B. subtilis LipM octanoyl transferase which efficiently modifies its 
cognate GcvH but fails to modify its cognate OADH LDs (Christensen, Martin et al. 
2011), and thus the OADH domains must obtain bound lipoate from GcvH by LipL-
catalyzed transfer (Christensen, Martin et al. 2011) (Fig. 4-1B). This lipoyl transfer 
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reaction is chemically challenging because the LipL active site thiol must attack a 
kinetically stable amide bond. Given this challenge it seems likely that GcvH provides 
an environment that facilitates the LipL reaction and that the OADH domains lack this 
property. To test this hypothesis we replaced the B. subtilis gcvH with genes encoding 
diverse GcvH and OADH LD proteins and tested for restoration of growth in the 
absence of lipoic acid. We also tested the proteins as acceptors of LipM-catalyzed 
octanoyl transfer in vitro. Substitution of E. coli GcvH for the B. subtilis protein would be 
particularly interesting because the E. coli does not use the lipoyl-relay pathway (Fig. 4-
1A).  Successful substitution would indicate that E. coli GcvH retains the ability to 
support lipoyl relay despite a lack of selection for this function. Moreover we also tested 
the seemingly redundant five copies of GcvH encoded in the small genome (1.5 Mb) of 
the deep branching bacterium, Aquifex aeolicus. These proteins were analyzed 
because Braakman and Smith (Braakman and Smith 2014) developed their hypothesis 
that GcvH is the primordial lipoylated protein based on their analysis of A. aeolicus. To 
our surprise two of these proteins were able to provide lipoyl-relay function to B. subtilis. 
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Materials and Methods 
Growth media and conditions  Bacterial strains used in the present study are listed in 
Table 2. E. coli and B. subtilis strains were routinely grown in Luria Bertani (LB) broth. 
For complementation assays, Spizizen salts (Spizizen 1958), supplemented with 0.5% 
glucose, trace elements and 0.01% each of tryptophan and phenylalanine were used as 
the minimal medium for B. subtilis. Antibiotics were added to medium at the following 
concentrations (μg ml-1): sodium ampicillin (Amp), 100; chloramphenicol (Cm), 5; 
kanamycin sulfate (Km), 5 and spectinomycin sulfate (Spec), 50. Lipoic acid (racemic) 
was added at 40 μM. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added at 0.5 
mM. Note that the lipoic acid requirement of ∆gcvH strains can be satisfied by a mixture 
of acetate and branched chain fatty acid precursors that bypass the lack of OADH 
activities. 
 
Phylogenetic analysis  The amino acid sequences of different species were retrieved 
from NCBI. Both the number of best scoring sequences and the number of best 
alignments were set to 1000. The e-values of the sequences selected were between 10-
40 and 10-50. The phylogenetic tree was constructed using the maximum likelihood 
method with the PhyML program (Guindon and Gascuel 2003, Chevenet, Brun et al. 
2006). PHYLIP Interleaved was used for alignment. The Bootstrap analysis was set to 
1000 replicates. 
 
Plasmid and Strain Constructions  Strain NM20 was complemented with ectopic 
gcvHs or OADH domains under control of an IPTG dependent promoter (Pspac). 
Plasmids pXC.045-pXC.056 was constructed by inserting PCR-amplified gcvH or OADH 
domain gene fragments into pDR111 (a gift of D. Rudner, Harvard Medical School 
(Wagner, Marquis et al. 2009)). The five putative gcvH genes from A. aeolicus gcvH1, 
KEGG entry aq_1052; gcvH2, KEGG entry aq_1657; gcvH3, KEGG entry aq_944, 
gcvH4: KEGG entry aq_1108; gcvH5, KEGG entry aq_402), the LD of S. coelicolor 
branched-chain 2-oxoacid dehydrogenase E2 (KEGG entry SCO3815), E. coli gcvH 
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(KEGG entry b2904), and S. coelicolor gcvH (KEGG entry SCO5471) were amplified 
from the corresponding genomic DNAs using Pfu DNA polymerase with primers 
oXC241/242, oXC247/248, oXC249/250, oXC251/252, oXC239/240, oXC259/oXC260, 
oXC233/0XC234, oXC271/272,  respectively, which added a ribosome binding site 
(aaaaccattatattaggaggaaataac) plus SphI and HindIII restriction sites. The E. coli PDH 
E2 (KEGG entry EC 1.2.4.1) lipoyl domain gene was amplified from plasmid pGS331 
(Ali and Guest 1990, Ali, Moir et al. 1990) using primers oXC235/236 which added the 
above ribosome binding site plus SalI and HindIII restriction sites. The H. sapiens 
sequence of the lipoyl domain of the pyruvate dehydrogenase E2 subunit (KEGG entry 
8050), the H. sapiens gcsH (KEGG entry K02437) and P. sativum gcvH (GenBank 
CAJ13840) were synthesized by IDT (Integrated DNA Technologies) as gBlocks Gene 
Fragments and were amplified with primers oXC257 and 258, oXC231 and 232, 
oXC237 and 238, respectively, adding ribosome binding site plus SphI and HindIII 
restriction sites as given above. Plasmids pXC.045-pXC.056 encoding GcvHs or OADH 
lipoyl domains were linearized and used to transform The B. subtilis ∆gcvH strain NM20, 
yielding strains XC.123-XC.129, XC.140, XC.141, XC.142, XC.147, XC.148 and XC.161, 
respectively. Transformants were selected on plates containing kanamycin and 
spectinomycin and screened for the amyE phenotype. The amyE phenotype was 
assayed with colonies grown for 24 h in LB starch plates by adding 10 ml of 1% I2-KI 
solution (Sekiguchi, Takada et al. 1975). Under these conditions amy positive colonies 
give a clear halo, whereas ∆amyE colonies produce no halo. 
 
To detect the expression levels of the proteins that failed to complement growth of strain 
NM20, insertion of a sequence encoding C-terminal His6 tag into the NM20 genomic 
gcvH/LD was performed. The genes that failed to complement were PCR-amplified with 
a forward primer containing the above ribosome binding site and a reverse primer 
encoding a His6 tag and a stop codon. E. coli gcvH, E. coli LD, H. sapiens LD, S. 
coelicolor LD, A. aeolicus gcvH2, gcvH3 and gcvH5 genes were amplified with primers 
oXC233/277, oXC235/278, oXC257/282, oXC259/283, oXC247/280, oXC249/281 and 
oXC239/279, respectively, and ligated into pDR111 to give the pXC.057 to pXC.063 
90 
 
plasmids. These plasmids were then linearized and transformed into NM20 generating 
strains XC.173-XC.179. Transformants were selected and screened for amyE 
phenotype as above. 
 
For purification of the protein products of the genes, the five A. aeolicus putative gcvH 
genes (gcvH1, gcvH2, gcvH3, gcvH4 and gcvH5) were amplified from corresponding 
genomic DNA using Pfu DNA polymerase with primers oHYQ188/189, oHYQ190/191, 
oHYQ192/193,oHYQ194/195, oHYQ165/166 respectively, which added NdeI and 
HindIII restriction sites. The products were digested with NdeI and HindIII and ligated 
into vector pET28b to express the N-terminally hexahistidine-tagged proteins. Plasmid 
pGS331, which expresses E. coli AceF LD under the control of the tac promoter, was 
the source of the E. coli AceF LD protein. The LD of H. sapiens PDH E2 and H. sapiens 
gcsH were PCR amplified with NdeI and BamHI restriction sites added. The NdeI and 
BamHI digested PCR fragments were ligated to pET28b generating pXC.043 and 
pXC.044 respectively. The expression vectors containing B. subtilis gcvH (KEGG entry 
BSU32800), LD of S. coelicolor branched-chain OADH E2, and S. coelicolor gcvH were 
from lab stocks (Table 4-2). 
 
Protein purification  GcvH and LD proteins were expressed and purified from strain 
BL21(DE3) (Table 4-2). Briefly, cultures were grown to OD600 0.5-0.8, in which 1 mM 
IPTG was added to induce protein expression. The cells were harvested after 3-5 h and 
suspended in lysis buffer (50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 1 mM tris(2-
carboxyethyl)phosphine (TCEP), 10 mM imidazole). The cells were lysed by 3 passages 
through a French Press apparatus after which the insoluble matters was removed by 
high-speed centrifugation and then filtration. Clear lysates were then incubated with Ni-
NTA agarose for 3-12 h at 5 °C, and washed/eluted using buffer with 10 to 250 mM 
imidazole. The concentrated proteins were dialyzed against 25 mM sodium phosphate 
buffer (pH7.2) containing 1 mM TCEP and further purified by ion exchange 
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chromatography using a Q column on an AFTA Purifier with increasing concentrations 
of NaCl. The purified proteins were then concentrated and dialyzed against 50 mM 
sodium phosphate (pH 7.2), 50 mM NaCl, 1 mM TCEP.  The B. subtilis Sfp, apo-ACP 
and LipM proteins, the Vibrio harveyi AasS and the E. coli AceF LD were purified as 
described previously (Jiang, Chan et al. 2006, De Lay and Cronan 2007). 
 
Conversion of apo-ACP to holo-ACP  The reaction mixture (100 μL) contained 100 
mM 2-(N-morpholino)ethanesulfonic acid(pH 6.0), 10 mM MgCl2, 5 mM dithiothreitol 
(DTT), 500 μM lithium CoA, 200 μM apo-ACP and 10 μM B. subtilis Sfp. The reaction 
was performed at 37°C for 3 h followed by incubation at 65°C for 2 h and the 
precipitates were removed by centrifugation. The remaining fraction containing holo-
ACP was analyzed by conformationally-sensitive 2 M urea PAGE (15% arylamide), and 
then dialyzed against 25 mM sodium phosphate (pH 7.0), 300 mM NaCl, 1 mM TCEP, 
10% glycerol.  
 
AasS/LipM coupled octanoyl-transfer reaction  The coupled reaction mixture (25 μL) 
contained 100 mM sodium phosphate (pH 7.2), 50 mM NaCl, 5 mM disodium ATP, 5 
mM TCEP, 2 mM MgCl2, 0.25 mM [1-14C] sodium octanoate, 50 µM holo-ACP, 2.5 μM 
AasS, 10 μM LipM and ~ 20 μM of one of the GcvH proteins. The reaction was 
performed at 37°C for 5 h. The products were electrophoresed on 2 M urea PAGE (20% 
arylamide), then dried under vacuum at 65°C for 2 h and exposed to preflashed Biomax 
XAR film (Kodak) at -80°C for 24 h. 
 
Western Blot Analysis  Anti-His6 primary antibody was utilized to probe protein 
expression as described previously (Cao, Zhu et al. 2017). Strains XC173 to XC179 
which encode genomic C-terminal His6-tagged versions of either a gcvH or a LD were 
grown to mid-log phase in Spizizen salts minimum medium plus trace elements, 0.5% 
w/v glucose, 0.01% tryptophan, 0.01% phenylalanine, 40 μM lipoic acid and 0.5 mM 
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IPTG. A 2 ml aliquot of each cell culture was harvested after 22 hours of growth. 
Soluble fractions of whole cell extracts were analyzed by SDS-PAGE. Equal amounts of 
protein were loaded and separated on a 12% SDS-polyacrylamide gel and transferred 
by electrophoresis to Immobilon-P membranes (Millipore) for 30 min at 60 V. The 
membranes were preblocked with TBS buffer (100 mM Tris base and 0.9% NaCl, pH 
7.5) containing 0.1% Tween 20 and 5% nonfat milk powder. The membranes were 
probed for 1 h with an anti-His6 protein primary antibody (ThermoFisher Scientific) 
diluted 1:2,000 in the above buffer. Following incubation with a peroxidase labeled anti-
mouse secondary antibody (diluted 1:5000; GE Healthcare Life Sciences), the labeled 
proteins (His6-tagged GcvH or LD) were detected using Quantity One software. 
Results  
Complementation of B. subtilis ∆gcvH lipoate auxotrophy by genes encoding 
alternative GcvH and OADH LD proteins.  To test the lipoyl-relay abilities of known 
and putative GcvH proteins from diverse organisms we used a B. subtilis ∆gcvH strain 
(NM20) in which deletion of the gcvH gene resulted in a requirement for lipoic acid 
(Martin, Lombardia et al. 2009, Christensen, Martin et al. 2011, Martin, Christensen et 
al. 2011). To test GcvH and LD proteins from other organisms for the ability to substitute 
for B. subtilis GcvH, the single GcvHs of E. coli, Streptomyces coelicolor, Pisum sativum 
(pea), Homo sapiens, all five putative GcvHs from A. aeolicus (Fig. 4-2) together with 
LDs from E. coli, S. coelicolor and H. sapiens were tested. Each gene was cloned and 
integrated into the chromosomal amyE site of the B. subtilis ∆gcvH strain under the 
IPTG-dependent promoter Pspac.  
 
This set of B. subtilis ∆gcvH strains was tested for relief of lipoic acid auxotrophy by 
colony formation in the absence of lipoic acid on minimal medium plates containing 
glucose as carbon source (Fig.4-3A). Slight background growth was observed on plates 
lacking IPTG, which is readily attributed to the known basal expression of the Pspac 
promoter and the low levels of lipoic acid required for growth. All of the strains grew well 
in the presence of lipoic acid indicating that the expressed proteins were not toxic to 
growth (Fig.4-3A). Interestingly, the GcvH proteins of E. coli and S. coelicolor supported 
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robust growth of the B. subtilis ∆gcvH strain in the absence of lipoic acid despite the fact 
that in their native hosts these GcvHs do not participate in lipoate synthesis. Expression 
of two eukaryotic GcvH proteins, the human (H. sapiens) and pea (P. sativum) proteins 
both of which are known to function in glycine cleavage (Douce, Bourguignon et al. 
2001, Kikuchi, Motokawa et al. 2008) also supported robust growth in the absence of 
lipoic acid. Indeed, the pea GcvH gave strong growth even in the absence of IPTG 
induction 
 
The five putative A. aeolicus GcvH proteins were problematical both in their number and 
lack of genome context.  The lack of genome context is characteristic of the A. aeolicus 
genome (Deckert, Warren et al. 1998). For example although the genes encoding the 
glycine cleavage system GcvP and GcvT proteins are almost always contiguous genes 
in bacteria, this is not the case in A. aeolicus, where even the two GcvP subunits are 
encoded remotely. The only clue as to which of the five putative GcvHs might be the 
“real” GcvH is GcvH4 which is encoded next to the GcvP2 subunit and indeed gave 
robust complementation. The GcvH1 protein also had complementation activity but 
more weakly than GcvH4. The GcvH2, GcvH3 and GcvH5 proteins were completely 
inactive in complementation as were all three of the OADH-LDs tested (those from E. 
coli, S. coelicolor and H. sapiens). 
  
To exclude the possibility that the lack of complementation was due to poor protein 
expression, we constructed a set of B. subtilis ∆gcvH derivatives in which the proteins 
that had failed to complement (GcvH2, GcvH3, GcvH5 from A. aeolicus) and the OADH 
LDs from E. coli, S. coelicolor and H. sapiens were tagged with a C-terminal 
hexahistidine sequence to allow immunological detection. The B. subtilis ∆gcvH strain 
expressing a tagged E. coli GcvH provided a positive control. As shown in Figure 4-3B, 
the three GcvH proteins (GcvH2, GcvH3 and GcvH5) from A. aeolicus and three LDs of 
E. coli, S. coelicolor and H. sapiens that failed to complement the B. subtilis ∆gcvH 
strain were all detected by western blotting and thus were expressed. Hence, the failure 
to complement could not be attributed to a lack of expression. 
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The proteins that failed to complement cannot be modified by LipM.  The inability 
of a given GcvH or OADH LD to complement the lipoate requirement of the B. subtilis 
∆gcvH strain could be due to an inability to accept octanoate in the reaction catalyzed 
by LipM or to transfer lipoate from GcvH to the OADH subunits, the LipL reaction (Fig.4- 
1). It is possible that a given protein could be inactive in both enzymatic reactions, but in 
the absence of LipM activity, LipL would have no substrate to transfer. Hence, the ability 
of a given protein to be modified by LipM but unable to complement OADH lipoylation 
could be attributed to defective LipL-catalyzed transfer. On the other hand modification 
by LipM would be expected for the proteins that showed complementation. To test these 
predictions we purified the GcvH proteins of E. coli, P. sativum, H. sapiens, S. 
coelicolor, the two complementing and three inactive putative GcvHs from A. aeolicus 
plus the LD of H. sapiens PDH by nickel affinity chromatography.  Some purified 
proteins migrated as doublets when analyzed on SDS PAGE gel (Fig. 4-4A) which is 
probably due to deamidation during purification and did not affect modification (Jordan 
and Cronan 1997, Robinson and Robinson 2001). Note that GcvH and LD proteins 
migrate on SDS PAGE at rates expected for proteins of about twice their size. This is 
because both GcvH and LD are very acidic proteins (calculated pIs ~3.9) and hence 
bind abnormally low amounts of SDS relative to the protein standards. We tested each 
protein for its ability to acceptor substrate for LipM-catalyzed [1-14C]octanoyl-transfer in 
vitro. The products were then analyzed by electrophoresis using conformationally-
sensitive urea PAGE (20%) rather than SDS PAGE because some of the GcvH proteins 
comigrated with B. subtilis acyl-ACP in the SDS system. Upon autoradiographic 
analysis of acceptor protein modification the GcvH proteins of B. subtilis, E. coli, S. 
coelicolor, H. sapiens, P. sativum, as well as GcvH1 and GcvH5 from A. aeolicus were 
readily octanoylated by LipM (Fig. 4-4B). In contrast no octanoyl transfer to the A. 
aeolicus GcvH2, GcvH3 and GcvH5 proteins or to the LD of H. sapiens PDH was 
observed (the LD from S. coelicolor PDH also failed to be modified - data not shown). 
These data indicate that the proteins that are unable to restore lipoic acid synthesis in 
vivo fail to complement because due to a lack of modification by LipM. Note that the [1-
14C]octanoyl-ACP was generated in situ using AasS (acyl-ACP synthetase) as 
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described in Materials and Methods. B. subtilis GcvH, the natural substrate of LipM, 
served as positive control in the reactions (Christensen and Cronan 2010).   
 
The putative GcvH2, GcvH3 and GcvH5 proteins of A. aeolicus cannot replace B. 
subtilis GcvH in glycine cleavage.  Glycine cleavage produces 5,10-methylene 
tetrahydrofolate, CO2, and NH3 (Fig. 4-2B). Bacteria that lack one of the gcv genes have 
two phenotypes. These are an inability to use glycine as a nitrogen source and an 
inability to supplement serine auxotrophs with glycine in place of serine (the 5,10-
methylene tetrahydrofolate produced by cleavage of a glycine molecule is used to 
convert another glycine molecule to serine). We have taken advantage of the first of 
these phenotypes to assess the abilities of the various GcvH and OADH LD proteins to 
function in B. subtilis glycine cleavage.  The ammonium sulfate of Spizizen salts 
minimal medium was replaced with potassium sulfate and glycine was added as the 
major nitrogen source (the NM20 strain also requires tryptophan and phenylalanine and 
grows best when the medium contains a small amount of acid hydrolyzed casein).  The 
presence of other nitrogen sources gave some background growth of the parental strain 
that ceased when the hydrolyzed casein nitrogen (mainly glutamate) was exhausted 
whereas in the presence of glycine growth continues robustly.  In contrast the B. subtilis 
∆gcvH strain NM20 showed only background growth.  Strains expressing each of the 
GcvH proteins of known to function in glycine cleavage (the human, pea, E. coli and B. 
subtilis proteins) allowed growth of the B. subtilis ∆gcvH strain on glycine as nitrogen 
source. The strain expressing A. aeolicus GcvH4 grew well with glycine as nitrogen 
source (Fig.4-6) consistent with the genomic location of the encoding gene.  Therefore, 
all of these proteins had both glycine cleavage and lipoyl-relay activity. The other 
annotated A. aeolicus GcvH proteins gave a variety of glycine cleavage phenotypes 
(Fig.4-6). The strain expressing GcvH2 proteins failed to grow on the glycine medium 
and the strain expressing GcvH5 gave only barely detectable growth, and thus have 
either no or extremely weak glycine cleavage activity and no in lipoyl-relay activity. The 
strain expressing the GcvH1 protein failed to grow on the glycine medium although it 
has weak lipoyl-relay activity. In contrast, the strain expressing the GcvH3 protein, 
which lacks lipoyl-relay activity, grew on the glycine medium. These data argue that the 
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residues responsible for lipoyl relay and glycine cleavage are not identical. Although 
most GcvH proteins have both functions, some have only lipoyl-relay activity or glycine 
cleavage activity. To our knowledge this is the first evidence that foreign GcvH proteins 
can function with non-cognate GcvP and GcvT proteins. As expected the OADH LD 
proteins were inactive in glycine cleavage.  
Discussion 
Despite the well-characterized role of lipoic acid as a protein-bound coenzyme, the 
detailed mechanisms of its synthesis and attachment to cognate proteins are still 
unclear in many organisms including bacteria and eukaryotes (Cronan 2016). The most 
straightforward lipoic acid synthesis pathway is the LipB-LipA pathway of E. coli (Fig. 4-
1) and numerous other bacteria where lipoyl-GcvH functions only in the glycine 
cleavage cycle. In marked contrast B. subtilis GcvH is not only a glycine cleavage 
system component but also has a moonlighting function in that it is required for 
lipoylation of the OADH enzymes required for aerobic metabolism and branched chain 
fatty acid synthesis.  
 
In their modeling studies of early evolution of metabolism based on the deep-branching 
hyperthermophilic chemoautotrophic bacterium, A. aeolicus, Braakman and Smith 
(Braakman and Smith 2014) argued that the glycine cleavage system first arose as part 
of the ancestral glycine/serine pathway and the sole function of lipoic acid was in 
shuttling the intermediates of this pathway. These authors further argued that utilization 
of lipoate in glycine cleavage preceded its use by the OADH enzymes because the TCA 
cycle is not essential in many bacteria whereas glycine cleavage is almost totally 
conserved. Their case was further buttressed by noting that those bacteria that lack the 
oxidative TCA cycle should lack LipL because there would be no OADH proteins to 
modify and this is the case (Braakman and Smith 2014). Moreover, the few bacteria that 
lack the genes of the glycine cleavage system would be expected to also lack the genes 
of lipoic acid synthesis and scavenging and once more this is the case. Together these 
considerations argue strongly that the B. subtilis pathway is derived from the ancestral 
pathway of lipoic acid attachment (Braakman and Smith 2014). It follows that transfer of 
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lipoic acid via the lipoyl-relay pathway to the OADH proteins can be considered as an 
energetically unfavorable “make-do” arrangement that was superseded by the 
energetically favorable direct transfer of octanoate to the OADH (and GcvH) proteins by 
broad specificity octanoyl transferases such as E. coli LipB.  In B. subtilis, transfer of 
lipoic acid from GcvH to the OADH proteins requires LipL which based on sequence 
and structural similarities seems to have been derived from LipM presumably by 
duplication of LipM with one of the copies subsequently acquiring amidotransferase 
activity (Khersonsky and Tawfik 2010, Tawfik 2010, Copley 2012, Braakman and Smith 
2014, Copley 2014).  Indeed, the above lipoate metabolism enzymes plus the biotin 
protein ligase that constitute Pfam PF03099 are all constructed on the same scaffold, 
albeit from diverse sequences and extra substrate-activating domains in the ligases 
(Cronan 2016). As mentioned above LipB and LipM share almost no sequence 
conservation and moreover the enzymes diverge in that their active site cysteine 
residues are on different loops of the common scaffold (Christensen and Cronan 2010). 
Hence transformation of a lipM gene to encode LipL activity may have been easier than 
conversion of either LipM or LplJ into a protein having LipB activity.   
 
At present LipB homologues are found only in the proteobacteria (often referred to as 
gram-negative bacteria) whereas LipM and LipL homologues are found only in gram-
positive bacteria such as the Firmicutes. These two types of bacteria are thought to 
have diverged about two billion years ago (Feng, Cho et al. 1997). A similar time 
estimate has been made for emergence of the organelles of bacterial origin, 
mitochondria and chloroplasts, where the lipoate-modified proteins are located (Feng, 
Cho et al. 1997). Hence, there seems ample time for genetic drift in the sequences of 
the bacterial and eukaryotic GcvHs we tested. Indeed, genetic drift is consistent with the 
low levels of strictly conserved residues (<10% or less, if the glycine residues required 
for the turns of anti-parallel β-sheets are put aside). However, despite this sequence 
drift the ability of GcvH to function in lipoate relay clearly arose early in bacterial 
evolution because two of the A. aeolicus proteins (GcvH4 and GcvH1) functionally 
replace B. subtilis GcvH although this bacterium lacks any OADH substrates to accept 
relayed lipoyl moieties. Moreover, lipoate-relay ability has been retained in the GcvH 
98 
 
proteins of bacteria (E. coli, S. coelicolor) that have no use for this proficiency because 
they utilize a different and more efficient lipoylation pathway. 
  
The most straightforward explanation of the curious state of affairs in which extremely 
diverse bacteria (A. aeolicus and E. coli) possess an activity that is metabolically 
extraneous would be that lipoate-relay ability is “hard-wired’ into GcvH proteins. In this 
scenario sequences required for glycine cleavage would also play important roles in the 
lipoyl-relay pathway. However, the A. aeolicus proteins show that this is not the case.  
The two proteins that are active in lipoate relay, GcvH4 and GcvH1, have different 
glycine cleavage activities. GcvH4 has good activity whereas GcvH1 lacks activity. 
Moreover GcvH3 and GcvH5 have modest and very weak glycine cleavage activities, 
respectively, but lack lipoate-relay activity. Finally GcvH2 lacks both activities. It has 
been argued that acquiring new specific interactions during evolution is neither difficult 
nor rare (Siddiq, Hochberg et al. 2017). In that hypothesis proteins continually gain and 
lose new activities, only a few of which contribute to fitness and are retained. Indeed, 
examples are known in which one or two residue changes can alter enzyme specificity 
and protein-protein interactions (Siddiq, Hochberg et al. 2017). This scenario may 
provide an explanation for the diverse activities of the five annotated A. aeolicus GcvH 
proteins. It may be that the GcvH structural scaffold permits lipoate-relay ability to arise 
frequently and that we have fortuitously “caught” the GcvH1 and GcvH4 proteins before 
lipoate relay will be lost by the stochastic processes of mutation and drift.  Note that due 
to the presence of other A. aeolicus proteins that have glycine cleavage activity, those 
proteins capable of lipoate relay are not required to retain activity in glycine cleavage. 
Indeed the presence of five closely similar proteins in A. aeolicus can be viewed as a 
license to allow evolutionary tinkering without loss of a fitness requirement. To extend 
these considerations to single copy GcvH proteins (e.g., that of E. coli) that have lipoyl-
relay activity but perform OADH modification by the direct pathway raises the possibility 
that the residues required for lipoyl relay may aid glycine cleavage and therefore 
provide some contribution to fitness. Sequence alignments give no obvious clues to 
explain the diversity among the lipoyl relay and glycine cleavage phenotypes. This 
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puzzle will have to be approached by genetic analyses. We will seek mutant GcvHs that 
have lost lipoyl-relay ability while retaining glycine cleavage activity and vice-versa.  
 
The putative GcvH protein, GcvH2, that failed to function in either lipoyl relay or glycine 
cleavage must be involved in another pathway(s) or is a (temporary?) evolutionary 
remnant. This may also be true of GcvH5 which has very weak glycine cleavage activity 
and no lipoyl-relay activity.  These two proteins seem closely related to each other and 
to GcvH3 which has only glycine cleavage activity (Fig. 4-5). The GcvH1 protein which 
has only lipoyl-relay activity seems off by itself whereas the GcvH4 protein which has 
both activities clusters with known GcvH proteins. However, a caveat to these 
comparisons is that these are small proteins and thus only a few residues substitutions 
are needed to alter groupings. As expected from prior analyses (Christensen and 
Cronan 2010) the OADH LDs and the GcvH proteins (perhaps excepting GcvH1) fall 
into separate clades.  
 
It should be noted that full transcription of bacterial glycine cleavage system genes 
proceeds only when high concentrations of glycine are present in the environment. For 
example addition of glycine to a wild-type E. coli culture growing in minimal medium 
results in a 30- to 60-fold increase in glycine cleavage activity (Steiert, Stauffer et al. 
1990, Wilson, Steiert et al. 1993). In E. coli the proteins required for glycine cleavage 
including GcvH are all encoded in a coordinately regulated operon except the 
dihydrolipoyl dehydrogenase subunit which is shared with the OADH complexes 
(Steiert, Stauffer et al. 1990). In B. subtilis induction of the glycine cleavage pathway is 
mediated by a glycine riboswitch which allows transcription in the presence of glycine 
(Mandal, Lee et al. 2004). A problem would arise if GcvH were under control of the 
riboswitch because OADH lipoylation (hence aerobic growth and fatty acid synthesis) 
would occur only in the presence of high glycine concentrations. However, in B. subtilis 
this predicament is avoided because the riboswitch controls only the genes that encode 
the GcvP and GcvT activities (Mandal, Lee et al. 2004). GcvH is encoded at a distant 
site in the genome and appears to be constitutively expressed (as required for OADH 
lipoylation). Indeed, a survey of genome sequences indicates that the genomic location 
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of gcvH in relation to gcvP and gcvT genes may provide a diagnostic for the mode of 
OADH lipoylation. That is, when the gene encoding GcvH is remote from those 
encoding the P and T subunits, the bacterium uses the lipoyl-relay pathway whereas in 
genomes where GcvH is encoded together with the P and T subunits, the direct (LipB) 
pathway is used.  
 
Note that a natural lipoate auxotroph, Listeria monocytogenes uses a modified lipoyl-
relay pathway. This bacterium acquires lipoic acid from its mammalian host cells and 
uses a ligase to attach it to GcvH followed by LipL-catalyzed lipoyl relay to its OADH 
proteins (Christensen, Hagar et al. 2011). Finally differential lipoylation of GcvH and the 
OADH proteins has recently been reported in Plasmodium falciparum, the causative 
agent of malaria. In this pathway, which seems descended from Chlamydia bacterial 
pathogens (Afanador, Guerra et al. 2017), a lipoate ligase called LipL1 proceeds 
through the usual lipoyl-AMP intermediate to attach host-derived lipoate to GcvH. 
However, LipL1 is unable to directly attach lipoate to the OADH proteins. Lipoylation of 
the OADH requires a second enzyme called LipL2 to transfer lipoate from the lipoyl-
AMP intermediate produced by LipL1 to the OADH proteins (but not to GcvH) 
(Afanador, Guerra et al. 2017).  Curiously the extant annotations indicate that neither P. 
falciparum nor Chlamydia species perform glycine cleavage. Chlamydia species lack 
recognizable genes that encode GcvP and GcvT subunits whereas P. falciparum lacks 
GcvP encoding genes. Hence, the physiological advantage of GcvH lipoylation is 
unclear in these organisms and it seems that these GcvH proteins like A. aeolicus 
Gcv2, Gcv3 and Gcv5 have other metabolic functions. 
 
101 
 
Tables 
Table 4-1. Oligonucleotides (5’-3’) 
   
   
oXC231 H. sapiens gcsH Forward (rbs,HindIII) TCTATAAGCTT aaaaccattatattaggaggaaataac ATGAGCGTGCGCAAATTCACAGAGA 
 
oXC232 
oXC233 
oXC234 
oXC235 
oXC236 
oXC241 
oXC242 
oXC247    
oXC248 
 
H. sapiens gcsH Reverse (SphI) 
E. coli gcvH Forward (rbs,HindIII) 
E. coli gcvH Reverse (SphI) 
E. coli gcvH Forward (rbs,SalI) 
E. coli gcvH Reverse (SphI) 
A. aeolicus gcvH1 Forward (rbs,HindIII)  
A. aeolicus gcvH1 Reverse (SphI) 
A. aeolicus gcvH2 Forward(rbs,HindIII) 
A. aeolicus gcvH2 Reverse (SphI) 
 
TCTATGCATGC TCACTCCTCAATGGATTTAATGTATTTTTCGTAGGCCTCTT 
TCTATAAGCTTaaaaccattatattaggaggaaataacATGAGCAACGTACCAGCAGAACTG 
TCTATGCATGCTTACTCGTCTTCTAACAATGCTTCGTATGCG 
TCTATGTCGAC aaaaccattatattaggaggaaataacATGAACGTTCCGGATATCGGCG 
TCTAT GCATGCTTAGAAGATCATAATCAGCGAGCCAGT 
CTATAAGCTTaaaaccattatattaggaggaaataacTTGTGGACTGATAGACTTTACAGAGTCGAAC 
TCTATGCATGCCTATTCTTCTACAATAGAACAATCTACATCCTCCAAAATTATAAAAT 
TCTATAAGCTT aaaaccattatattaggaggaaataac ATGGCGGAAAAGGTTGAAGAATACAGGG 
GCGAGTCAGTAAAGTTCTGTCTCGCCATTTCAAAAGCCACCATATGAATATCCTCCT 
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Table 4-1 
oXC249 
oXC250 
oXC251 
oXC252 
oXC239 
oXC240 
oXC237 
oXC238                              
(cont.) 
A. aeolicus gcvH3 Forward(rbs,HindIII) 
A. aeolicus gcvH3 Reverse (SphI) 
A. aeolicus gcvH4 Forward(rbs,HindIII) 
A. aeolicus gcvH4 Reverse (SphI) 
A. aeolicus gcvH5 Forward(rbs,HindIII) 
A. aeolicus gcvH5 Reverse (SphI) 
P. sativum gcvH Forward (rbs,HindIII) 
P. sativum gcvH Reverse (SphI) 
 
 
TCTATAAGCTTaaaaccattatattaggaggaaataacATGGGGAAGCAGGAGAAGGACTTA 
TCTAT GCATGCTCACACACACCTCATACAAACTATATCCC 
TCTATAAGCTT aaaaccattatattaggaggaaataacATGGAAGACTTCTACGTTGAAGATTACC 
TCTATGCATGCTCATTTATTCTCCTCGTATCCGAGTTCTTCTTCG 
TCTATAAGCTTaaaaccattatattaggaggaaataacATGGCAGAAGTAAACGGGTGCCAA 
TCTATGCATGC TTAACCGCACTTAACTCCTTTTTCTTGAACTATTGG 
TCTATAAGCTTaaaaccattatattaggaggaaataacATGTCAAACGTACTTGATGGTCTGAAATAC 
TCTATGCATGC TTAAGCCGCGTCCTCTTCTTCGC 
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Table 4-1        
oXC257 
oXC258 
oXC259 
oXC260 
oXC271 
oXC272 
(cont.) 
H. sapiens LD Forward(rbs,HindIII) 
H. sapiens LD Reverse (SphI) 
S. coelicolor LD Forward 
S. coelicolor LD Reverse (SphI)   
S. coelicolor gcvH Forward (rbs) 
S. coelicolor gcvH Reverse (sphI)      
 
     
TCTATAAGCTTaaaaccattatattaggaggaaataacATGGGCAGTAACATGAGTTACCCA 
    TCTATGCATGCTCATTTAAGATCTGTGACCTCAGTGGGACGATAATCTG 
    TCTATAAGCTTaaaaccattatattaggaggaaataacATGGAGTTCAAGTGCCCGACCTCG 
    TCTATGCATGCTCACTCGGTGCCCTCCTCGCCGAAG 
TCTATAAGCTTaaaaccattatattaggaggaaataacATGAGCAACCCCCA 
TCTATGCATGCTCAGGCGCCGGCGAAGGCGG   
oXC277 
oXC278 
oXC279 
oXC280 
oXC281 
oXC282   
oXC283  
E. coli gcvH Reverse, His6 (SphI) 
E. coli LD Reverse, His6, (SphI) 
A. aeolicus gcvH5, Reverse, His6   
A. aeolicus gcvH2, Rverse, His6 
A. aeolicus gcvH3, Reverse, His6 
H. sapiens LD Reverse, His6 (SphI) 
S. coelicolor LD Rverse, His6 
TCTATGCATGCTTAgtgatggtgatggtgatg CTCGTCTTCTAACAATGCTTCGTATGCG 
TCTAT GCATGCTTAgtgatggtgatggtgatgGAAGATCATAATCAGCGAGCCAGT 
TCTGCATGCTTAgtgatggtgatggtgatACCGCACTTAACTCCTTTTTCTTGAACTAT 
 TCTATGCATGCTCAgtgatggtgatggtgatgTTTATAGAATTTTTTACTGATTTGGGCTCTC 
TCTATGCATGCTCAgtgatggtgatggtgatgCACACACCTCATACAAACTATATCCC 
TCTATGCATGCTCAgtgatggtgatggtgatgTTTAAGATCTGTGACCTCAGTGGGACGATAATCTG 
TCTATGCATGCTCA gtgatggtgatggtgatgCTCGGTGCCCTCCTCGCCGAAG 
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Table 4-1 
oHYQ165 
oHYQ166 
oHYQ188 
oHYQ189 
oHYQ190  
oHYQ191 
oHYQ192 
oHYQ193 
oHYQ194 
oHYQ195 
 
(cont.) 
A. aeolicus gcvH5 Forward (NdeI) 
A. aeolicus gcvH5 Reverse (HindIII) 
A. aeolicus gcvH1 Forward (NdeI) 
A. aeolicus gcvH1 Reverse (HindIII) 
A. aeolicus gcvH2 Forward (NdeI) 
A. aeolicus gcvH2 Reverse (HindIII) 
A. aeolicus gcvH3 Forward (NdeI) 
 A. aeolicus gcvH3 Reverse (HindIII) 
A. aeolicus gcvH4 Forward (NdeI) 
A. aeolicus gcvH4 Reverse (HindIII) 
 
 
 
TTCCCATATGGCAGAAGTAAACGGGTGCCAA 
TCTAAAGCTTTTAACCGCACTTAACTCCTTTTTCTTGAACTATTGG 
TTCCCATATGTGGACTGATAGACTTTACAGAGTCGAACC 
TCTATAAGCTTCTATTCTTCTACAATAGAACAATCTACATCCTCCAAAATTATAAAAT 
TTCCCATATGGCGGAAAAGGTTGAAGAATACAGGG 
TCTAAAGCTTTCATTTATAGAATTTTTTACTGATTTGGGCTCTCTCTTCA 
TTCCCATATGGGGAAGCAGGAGAAGGACTTA 
TCTAAAGCTTTCACACACACCTCATACAAACTATATCCC 
TTCCCATATGGAAGACTTCTACGTTGAAGATTACCTTG 
TCTAAAGCTTTCATTTATTCTCCTCGTATCCGAGTTCTTCTTCG 
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Table 4-2.Strains and plasmids used in Chapter 4 
Strains                  
E. coli 
Ref. or Derivation 
 
BL21(DE3) 
HYQ141 
HYQ155 
HYQ158 
HYQ160 
HYQ161 
HYQ162 
HYQ163 
XC.082 
XC.092 
B. subtilis 
JH642 
NM20 
XC.123 
XC.124 
XC.125 
XC.126 
Lab stock 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
 
Lab stock 
Lab stock 
This study 
This study 
This study 
This study 
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Table 4-2 
XC.128 
XC.129 
XC.140 
XC.141 
XC.142 
XC.147 
XC.148 
XC.161 
XC.173 
XC.174 
XC.175 
XC.176 
XC.177 
XC.178 
XC.179 
(cont.) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
  
Plasmids  
pET28b 
pDR111 
Novagen 
Lab stock 
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Table 4-2 
pXC.003 
pXC.004 
pXC.005 
pXC.043 
pXC.044 
pXC.045 
pXC.046 
pXC.047 
pXC.048 
pXC.049 
pXC.050 
pXC.051 
pXC.052 
pXC.053 
pXC.054 
pXC.055 
pXC.056 
pXC.057 
pXC.058 
(cont.) 
Lab stock 
Lab stock 
Lab stock 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
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Table 4-2 
pXC.059 
pXC.060 
pXC.061 
pXC.062 
pXC.063 
pHYQ33 
pHYQ37 
pQC036 
pHYQ38 
pHYQ39 
pHYQ40 
pHYQ41 
 
 
 
 
                  
(cont.) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
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Figures 
 
             Figure 4-1. Lipoic acid synthesis and scavenge in E. coli and B. subtilis.  A.  The E. coli 
lipoic acid synthetic pathway requires only two proteins, LipB and LipA. The LipB 
octanoyl-ACP transferase transfers the octanoyl moiety from the fatty acid biosynthetic 
intermediate, octanoyl-ACP, to both OADH LDs and GcvH where LipA catalyzed sulfur 
insertion converts it to lipoate.  B.  The B. subtilis lipoic acid synthetic pathway requires 
four proteins (three enzymes plus the GcvH protein on which lipoate is assembled and 
donated to the OADH proteins instead of the two enzymes of the simpler E. coli 
pathway of panel B.  Like E. coli, B. subtilis has the LipA sulfur insertion enzyme and an 
octanoyl transferase, LipM, although LipM is an isozyme rather than a homologue of the 
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Figure 4-1 (cont.) E. coli LipB octanoyl transferase. The octanoylated GcvH then 
becomes a substrate for LipA-catalyzed sulfur insertion at carbons 6 and 8 (as in panel 
A). The lipoyl moiety is then relayed from GcvH to the OADH subunits by an 
amidotransferase called LipL.   C.  Both bacteria scavenge lipoate from the medium by 
use of the reaction shown for the E. coli lipoate ligase, LplA.  The B. subtilis ligase is 
LplJ (Martin, Christensen et al. 2011). The two ligases (which are 33% identical) are 
required for lipoate supplementation of strains blocked in lipoic acid synthesis. E. coli 
LplA efficiently lipoylates both its cognate GcvH and the OADH domains (Morris, Reed 
et al. 1994) whereas in B. subtilis GcvH is a much better LplJ substrate than are the 
OADH proteins (Martin, Christensen et al. 2011).  
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Figure 4-2. Amino acid sequence alignments of known and putative GcvH proteins and 
the central role of GcvH in the glycine cleavage mechanism. A. Sequence alignment of 
GcvH proteins of E. coli, Homo sapiens, Pisum sativum, Streptomyces coelicolor, B. 
subtilis and five putative Aquifex aeolicus GcvH proteins (GcvH1, GcvH2, GcvH3, 
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Figure 4-2 (cont.) GcvH4, GcvH5). Conserved residues are shown as white letters on a 
red background, and similar residues are shown as red letters in blue boxes. The E. coli 
GcvH secondary structure (Protein Data Bank ID 3A7L) is shown at the top of the panel. 
The vertical arrow denotes the lysine residue that becomes modified.  B. The glycine 
cleavge system and the central role of GcvH. Note that the L protein that oxidizes the 
lipoyl cofactor is the same protein as the dihydrolipoyl dehydrogenase (Lpd) of the 
OADH complexes. 
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Figure 4-3.  A, Growth of B. subtilis ∆gcvH strains expressing genes encoding various 
GcvHs and LDs. The genes were integrated into the chromosomal amyE site of the B. 
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Figure 4-3 (cont.) subtilis ∆gcvH strain under control of Pspac promoter. The B. subtilis 
∆gcvH NM20 strain is auxotrophic for lipoic acid and thus growth in the absence of lipoic 
acid denoted complementation. Colony formation was tested on minimal agar plates 
with glucose as the sole carbon source in the presence or absence of lipoic acid and 
growth was scored after 36 h at 37°C.  The IPTG concentration was 0.5 mM. The wild 
type (JH642) and B. subtilis ∆gcvH (NM20) strains served as positive and negative 
controls, respectively. B, Western blot analysis of GcvH and LD expression. The strains 
expressing proteins that failed to complement growth of the B. subtilis ∆gcvH strain 
were grown for 22 h in minimal medium with lipoic acid and 0.5 mM IPTG. Crude cell 
extracts were separated on SDS-PAGE gels and immunoblotted with anti-hexahistidine 
antibody (Materials and Methods). Crude extracts of the B. subtilis ∆gcvH amyE:: 
Pspac-E. coli gcvH-His6 strain (XC173) were used as the positive control. Crude 
extracts of B. subtilis ∆gcvH derivatives expressing the various gcvH and OADH LD 
proteins are as indicated. 
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Figure 4-4. Purification and octanoyltransferase assays of GcvH and LD proteins. A, 
Purification of the GcvH and LD proteins. The proteins were purified as described in 
Materials and Methods and analyzed by SDS-PAGE on a 4-20% polyacrylamide gel. 
The molecular weights of the prestained broad-range protein standards (Bio-Rad) are 
indicated. 1: B. subtilis GcvH, 2: H. sapiens LD, 3: E. coli GcvH, 4: S. coelicolor GcvH, 5: 
P. sativum GcvH, 6: H. sapiens GcsH, 7-11: GcvH1, GcvH2, GcvH3, GcvH4 and GcvH5 
from A. aeolicus, respectively. B, Assay of [1-14C]octanoyl transfer from [1-14C]octanlyl-
ACP to GcvH and LD proteins as indicated in the picture. The [1-14C]octanoyl-ACP was 
synthesized in situ from [1-14C]octanoate by AasS added to the reaction (ATP was 
added for the AasS reaction). Synthesis of [1-14C]octanoyl-ACP required [1-
14C]octanoate, AasS, ATP and holo-ACP whereas formation of [1-14C]octanoyl-
GcvH/LD required apo-GcvH or LD, LipM and [1-14C]octanoyl-ACP. 
  
 116 
 
Figure 4-5. The phylogenetic tree of the GcvH and OADH LD obtained using the PhyML 
program maximum likelihood method (Guindon and Gascuel 2003, Chevenet, Brun et al. 
2006). The tree is drawn to scale. The branch lengths are in the same units as the 
evolutionary distances. 
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Figure 4-6.  Glycine cleavage activitites of the A. aeolicus GcvH homologues. The 
medium was modified Spizizen lacking ammonium sulfate and supplemented with 0.01% 
each of L-phenylalanine and L-tryptophan and 0.015% acid hydrolyzed casein.  Either 
glycine or L-glutamic acid (a preferred nitrogen source for this bacterium) was added at 
0.1%.  The plates were incubated at 37° C for 72 h. No discrete colonies were formed 
by the strains that expressed GcvH1 and GcvH2 (only scratches from the streaking) 
whereas barely visible colonies were formed in the scratches by the strain that 
expressed GcvH5. 
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 CHAPTER 5 
 CONCLUSIONS AND FUTURE DIRECTIONS  
 
The metabolic roles of lipoic acid and biotin as coenzymes have been known for 
decades, and the model mechanisms by which lipoic acid and biotin is synthesized and 
attached to their cognate proteins are well characterized in E. coli and B. subtilis 
respectively. However, the synthetic pathways of lipoic acid and biotin in other 
organisms have remained elusive. The studies present in this thesis further explained 
the diversified and novel functions of lipoic acid and biotin synthesis proteins in several 
other bacteria.  
 
In Chapter 2, I report that the domain structure of the Streptomyces coelicolor lipoate-
protein ligase (LplA), which encode an circular permutated architecture relative to the 
canonical one, can be restructured into that of the paradigm Escherichia coli ligase. This 
indicates that the domain architectures of lipoate-ligases are plastic. The fact that when 
the two domains of S. coelicolor LplA were separated into two polypeptide chains and 
still carry out both the lipoate activation and lipoyl transfer partial reactions in vivo and in 
vitro, suggests that the domains of bacterial lipoate ligases can act as independent 
entities.  
 
Identification of a protein as encoding a lipoate-protein ligase is not straightforward 
because members of this biotin protein ligase-LplA-LipB protein family (Pfam 03099) 
catalyze three other reactions: octanoyl transfer from octanoyl-ACP, amido transfer in B. 
subtilis, and ligation of biotin to its cognate proteins. There are lots of proteins involved 
in this Pfam family to which the true function needs to be correctly characterized. First of 
all, is the human and bovine lipoate protein ligases (LipT1). Previous studies showed 
that LipT1 could only catalyze the second partial reaction: transfer of the lipoyl moiety 
form lipoyl-adenylate to the cognate proteins, and the first partial reaction, synthesis of 
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the adenylate, is performed by a “lipoate activating enzyme” (Fujiwara, Okamura-Ikeda 
et al. 1994, Fujiwara, Takeuchi et al. 2001). However, this proposed “lipoate activating 
enzyme” lacks physiological relevance (see Chapter 1, “Lipoate-protein ligase”). We 
hypothesize that the true function of LipT1 is physiologically an amidotransferase, same 
function as LipL in B. subtilis, and the half ligase activity is just an evolution relic when 
LipT1 was a true ligase. In order to test our hypothesis, I purified bovine LipT1 and 
pyruvate dehydrogenase lipoyl domain (LD) to homogeneity, and also synthesized the 
substrate lipoyl-GcsH. The reaction was performed in vitro and the lipoylated LD was 
detected by western blotting using anti-lipoic acid antibody. LipT1 showed clear 
amidotransferase activity that transferred lipoyl moiety from GcsH to LD (data not 
published yetI also purified bovine LipT2 protein and found LipT2 could catalyze the 
formation of octanoyl-GcsH in vitro. Dr. John Cronan showed that LipT2 could also 
complement E. coli ∆lipB strain (data not published). Another interesting thing I 
observed was that LipT1 had no or extremely low activity upon octanoyl-GcsH. However, 
this needs to be further confirmed by a more accurate radioactive assay using 
synthesized [1-14C]octanoyl-GcsH as substrate. If LipT1 was confirmed to show activity 
only upon lipoyl-GcsH instead of octanoyl-GcsH, then we can make the conclusion that 
LIAS protein (same function as LipA in E. coli) inserts sulfur atoms onto octanoyl moiety 
right after the catalysis of LipT2 but before LipT1. In the future, one can try to inhibit the 
half ligase activity of LipT1 while still retain the amidotransferase activity by residue 
mutagenesis and vice versa. 
 
By collaborating with Dr. Christiane Dahl from Bonn, Germany, we set out to verify a 
novel group of bifunctional proteins in sulfur-oxidizing bacteria that is poised to have 
both lipoate ligase activity and octanoyl transferase activity (data not published yet). 
More interestingly, this group of proteins only possess a single domain and the dual 
catalytic activity is restricted in kind to acceptor proteins that are readily divided into two 
distinct groups called LbpA1 and LbpA2 (i.e., lipoate binding protein A1 and A2), which 
are also involved in sulfur oxidation pathways. LbpA1 and LbpA2 has about  25% 
sequence identity to GcvH proteins and they were labeled “glycine cleavage protein H” 
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in the KEGG website. In vitro biochemical assays showed this bifunctional protein has 
lipoate ligase activity only upon LbpA1 and octanoyl transfrase activity only upon LbpA2. 
Neither LbpA1 nor LbpA2 could complement B. subtilis ∆gcvH strain indicates that they 
could not participate in lipoate relay reaction as most GcvH proteins do (see Chapter 4). 
Further experiments are also required to test if LbpA1 and LbpA2 truly have the glycine 
cleavage activity. However, whether LbpA1or LbpA2 is essential in the sulfur oxidization 
pathway is elusive. Additionally, the reason why a large domain alone could be 
sufficient for both ligase partial reactions (synthesis of lipoyl-adenylate and transfer of 
lipoate to the cognate proteins) are not clear, either because previous studies have 
confirmed that both the small and large domain are required to form the lipoyl-adenylate. 
A crystal structure of the bifunctional protein in complex with LbpA1 and LbpA2 would 
be highly valuable in this regard.  
 
In Chapter 3, I resolved a long-standing puzzle remained in the biotin synthesis protein 
BioH. The “wild” nature of BioH/bioH led us to make the hypothesis that the BioH 
encoded by an operon-encoded gene might differ in its expression level and/or activity 
from the freestanding BioH gene.  We report that this is not the case. The two BioH 
proteins show remarkably similar hydrolase activities and substrate specificity. 
Moreover, the Pseudomonas aeruginosa BioH is more highly expressed than E. coli 
BioH. Despite the enzymatic similarities of the two BioH proteins, bioinformatics 
analysis places the freestanding and operon-encoded BioH proteins into distinct clades. 
 
In Chapter 4, I found most known and putative GcvH proteins from other bacteria and 
eukaryotes including E. coli GcvH also substitute for B. subtilis GcvH in OADH 
modification. This is surprising because E. coli pathway where lipoate is directly 
assembled on both its GcvH and OADH proteins, is proposed to arise later than the 
primordial lipoate relay pathway in B. subtilis. Our findings provide a remarkable case in 
which a protein “moonlighting” function is found throughout evolution without selection 
for the function.  Moreover, the deep-branching hyperthermophilic Aquifex aeolicus 
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bacterium encodes five putative GcvHs, two of which have the “moonlighting” function 
(function in both glycine cleavage system and lipoate relay reaction) whereas another 
two function only in glycine cleavage. This extends our consideration that the catalytic 
residues of lipoate relay and glycine cleavage activity do not overlap with each other. In 
the future one can seek mutant GcvHs that have lost lipoyl-relay ability while retaining 
glycine cleavage activity and vice-versa. 
 
To summarize, the studies presented in this thesis have answered some remaining 
questions involving the lipoic acid and biotin metabolism in various organisms. This 
enables predictions of new lipoic acid and biotin synthesis pathways and reveals novel 
protein mechanisms and enzymology.  
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